data_2axk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2axk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.838 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 77.9 mt . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.03 0.443 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -116.37 101.54 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.712 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.417 ' HG1' ' CG2' ' A' ' 6' ' ' VAL . 18.4 p -90.11 3.16 54.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.36 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t30 57.82 51.75 8.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 122.193 0.997 . . . . 0.0 109.693 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 85.9 t -124.57 118.6 53.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.705 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.17 148.29 48.46 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.506 0.503 . . . . 0.0 109.725 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.422 ' C ' ' H ' ' A' ' 10' ' ' GLY . 29.4 p -86.74 111.42 20.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.492 0.663 . . . . 0.0 111.536 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -86.43 32.91 0.63 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 8' ' ' CYS . . . 113.18 128.83 4.94 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.53 -170.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 m -61.07 -19.02 60.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.071 0.436 . . . . 0.0 110.83 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.444 ' HA ' HG13 ' A' ' 15' ' ' VAL . 13.3 m -81.7 -5.84 58.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.763 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.568 ' HB2' ' HZ3' ' A' ' 13' ' ' LYS . 3.6 ttmp? -82.97 -51.19 7.8 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -62.39 -46.96 86.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.986 -178.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 12' ' ' SER . 7.1 p -57.67 -27.99 31.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.675 0.274 . . . . 0.0 111.524 -175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -88.97 -43.84 10.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.731 0.301 . . . . 0.0 111.174 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 13' ' ' LYS . 3.1 tp -82.29 -29.69 9.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.0 0.428 . . . . 0.0 112.031 -173.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.633 ' HA ' ' HD2' ' A' ' 21' ' ' ARG . 7.7 t -65.47 -20.24 66.27 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.061 0.458 . . . . 0.0 110.056 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 25' ' ' ARG . 66.5 mt -64.74 -39.46 85.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.312 173.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.63 -23.53 49.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.063 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.633 ' HD2' ' HA ' ' A' ' 18' ' ' CYS . 99.7 mtt180 -67.41 -67.43 0.46 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.267 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.11 -94.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.002 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -160.08 18.4 0.15 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 -174.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.497 ' HB ' ' HG3' ' A' ' 38' ' ' PRO . 8.4 t -103.73 161.1 14.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.05 0.452 . . . . 0.0 110.855 -173.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.422 ' HA ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -124.39 10.15 8.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.465 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.57 119.29 1.46 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.04 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -141.16 144.56 34.89 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -141.64 145.59 35.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.994 0.426 . . . . 0.0 110.918 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 29.3 t -86.18 110.24 19.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -116.85 -46.57 3.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.474 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.505 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 27.3 p-10 -108.25 20.04 19.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.236 0.541 . . . . 0.0 110.603 -176.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.86 -6.07 54.15 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.057 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 11.4 ptp180 -130.95 167.99 18.08 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.9 m -89.98 113.08 24.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.8 m -112.55 135.67 53.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.573 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.838 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 17.7 m -99.7 130.78 45.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.798 0.332 . . . . 0.0 110.284 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -120.78 86.22 40.62 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.612 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 2.9 Cg_exo . . . . . 0 C--O 1.251 1.17 0 C-N-CA 123.149 2.566 . . . . 0.0 111.969 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.3 mt . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -103.46 125.49 50.07 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.7 p -75.63 -22.16 57.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.344 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 65.67 36.86 6.12 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.504 1.145 . . . . 0.0 108.65 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 3.2 t -135.8 114.47 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 112.929 -1.942 . . . . 0.0 110.222 -172.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 143.47 56.57 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.041 0.448 . . . . 0.0 110.319 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 p -122.22 160.6 24.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.644 -172.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 p -85.93 -48.65 8.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.276 172.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.54 162.55 25.46 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.788 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 20.5 m -62.13 -18.78 61.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.2 0.5 . . . . 0.0 111.346 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.5 p -64.68 -15.35 61.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.193 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -62.18 -55.2 31.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.921 0.391 . . . . 0.0 111.441 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 9.6 m -82.51 -41.67 19.41 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 2.5 p -51.22 -33.64 13.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -172.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -46.43 10.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.753 0.311 . . . . 0.0 110.735 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.644 HD11 ' HB3' ' A' ' 20' ' ' ASP . 3.5 tp -77.43 -29.55 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 111.937 -171.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -64.33 -15.91 61.21 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.776 178.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.9 mt -85.65 -25.53 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.153 0.502 . . . . 0.0 110.216 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.644 ' HB3' HD11 ' A' ' 17' ' ' ILE . 13.4 t70 -85.55 -32.89 21.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.473 0.654 . . . . 0.0 109.904 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.565 ' HD2' HG13 ' A' ' 17' ' ' ILE . 58.2 mtp180 -89.25 -41.92 11.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.728 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.27 -116.53 0.29 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -164.4 101.95 0.83 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.605 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.53 HG23 ' HB3' ' A' ' 36' ' ' CYS . 70.0 p -133.92 163.0 30.49 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.001 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.35 -39.22 7.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.61 150.86 23.15 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.291 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HB1' ' N ' ' A' ' 15' ' ' VAL . . . -141.31 137.21 32.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -126.39 139.28 53.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.998 0.428 . . . . 0.0 111.099 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.788 ' SG ' ' HA ' ' A' ' 11' ' ' SER . 56.0 m -79.83 107.05 12.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.51 173.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.5 tp -117.58 -45.25 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.05 -171.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -97.82 16.34 21.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.139 0.971 . . . . 0.0 109.873 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.65 -13.88 64.82 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 14.5 ptt180 -122.53 165.34 16.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.286 -0.957 . . . . 0.0 108.658 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 2.0 p -96.83 119.38 35.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.288 0.566 . . . . 0.0 111.715 -172.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.0 m -99.55 131.87 45.26 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.558 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.565 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 29.5 m -98.5 135.78 39.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -113.91 90.63 19.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.105 0.479 . . . . 0.0 111.039 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 32.8 Cg_endo . . . . . 0 N--CA 1.444 -1.398 0 C-N-CA 124.395 3.397 . . . . 0.0 111.9 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.842 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 78.1 mt . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.635 0.255 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -122.65 122.57 39.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.079 0.466 . . . . 0.0 110.264 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 p -97.17 1.16 49.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.892 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.683 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 37.4 t30 52.98 71.71 0.47 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.966 0.888 . . . . 0.0 110.119 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.2 t -134.68 110.06 12.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.514 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HE3' ' HB3' ' A' ' 7' ' ' LYS . 23.8 mmmt -48.82 117.73 2.21 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.692 0.62 . . . . 0.0 110.232 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.1 p -83.0 145.84 29.1 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.108 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p -103.28 28.35 6.45 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.876 171.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.13 -113.54 0.94 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.782 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.1 p -164.38 -27.66 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.892 0.377 . . . . 0.0 110.385 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.41 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 10.7 p -60.59 -14.86 22.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.856 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.434 ' O ' HG21 ' A' ' 17' ' ' ILE . 4.7 tmtm? -69.12 -61.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -63.61 -48.72 76.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.45 -174.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 6.0 p -54.15 -33.51 25.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -86.36 -52.04 5.86 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.162 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.6 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 4.1 tp -72.03 -32.05 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -172.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 t -60.77 -24.19 65.58 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.977 0.417 . . . . 0.0 110.356 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.8 mt -69.72 -39.44 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.809 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.576 ' HB2' HD12 ' A' ' 17' ' ' ILE . 16.4 m-20 -77.41 -14.08 59.78 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.097 0.475 . . . . 0.0 110.65 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.6 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 49.0 mtm180 -98.65 -47.6 5.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.845 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -115.1 -109.11 0.36 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -161.85 15.57 0.09 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.067 0.461 . . . . 0.0 110.881 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 t -104.54 139.84 38.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.994 0.426 . . . . 0.0 110.821 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.568 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -101.67 -2.65 29.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.643 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.9 97.87 0.84 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.994 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . . . -131.88 131.35 42.68 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 26.4 ttpt -133.36 148.93 51.87 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.116 -176.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 15.0 t -85.87 127.16 34.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 172.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.533 HG23 ' H ' ' A' ' 31' ' ' ASN . 4.3 tp -112.75 -71.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.729 -176.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.533 ' H ' HG23 ' A' ' 30' ' ' ILE . 21.6 t-20 -98.27 40.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.519 0.676 . . . . 0.0 109.922 -176.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.64 3.79 70.91 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.259 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.683 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 5.9 ptp180 -134.19 157.08 47.15 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 1.5 m -89.08 120.46 30.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.998 0.428 . . . . 0.0 111.499 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.0 m -123.29 139.91 53.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.726 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.842 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 32.8 m -99.07 132.29 44.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -119.93 83.76 30.89 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.136 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo . . . . . 0 C--O 1.246 0.92 0 C-N-CA 122.838 2.359 . . . . 0.0 111.711 177.491 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.848 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 87.5 mt . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.406 0.622 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -90.82 106.71 18.7 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.423 ' OG1' ' HB ' ' A' ' 6' ' ' VAL . 24.8 p -75.37 -24.74 57.31 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.423 -173.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.819 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 66.2 t30 67.26 40.37 2.79 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 122.832 1.301 . . . . 0.0 107.664 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 5.1 t -124.04 126.83 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 112.999 -1.91 . . . . 0.0 109.747 -170.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -60.55 144.16 52.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.345 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.651 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 4.1 p -104.7 129.48 52.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.15 0.5 . . . . 0.0 111.905 -176.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 m -96.46 21.46 9.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.639 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.76 34.66 0.9 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.038 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.465 ' O ' HG12 ' A' ' 15' ' ' VAL . 68.7 m 71.46 -37.64 0.4 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.479 0.712 . . . . 0.0 112.9 175.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.561 ' HA ' HG12 ' A' ' 15' ' ' VAL . 22.0 t -62.4 -19.96 63.97 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.455 0.645 . . . . 0.0 109.909 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -57.22 -43.23 82.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.706 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -97.52 -49.24 4.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.283 -175.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 12' ' ' SER . 14.9 p -62.11 -8.95 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.367 0.603 . . . . 0.0 111.666 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.489 ' HB3' ' HZ1' ' A' ' 16' ' ' LYS . 7.6 ttpm? -96.8 -51.49 4.26 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.997 -0.439 . . . . 0.0 110.703 174.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.619 HD12 ' HB3' ' A' ' 20' ' ' ASP . 1.7 tp -85.32 -32.85 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.1 t -62.85 -25.81 68.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.45 0.643 . . . . 0.0 109.704 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.653 HG13 ' O ' ' A' ' 24' ' ' THR . 1.7 mp -77.63 -33.4 19.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.404 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.619 ' HB3' HD12 ' A' ' 17' ' ' ILE . 8.5 t70 -76.17 -35.83 58.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.363 0.602 . . . . 0.0 109.64 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -75.35 -52.56 10.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.254 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -111.93 -113.57 0.33 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.113 0.483 . . . . 0.0 112.246 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -159.04 19.73 0.19 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.52 -170.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.653 ' O ' HG13 ' A' ' 19' ' ' ILE . 9.0 t -100.77 171.48 7.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.145 -174.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.5 -1.35 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.031 0.443 . . . . 0.0 110.347 173.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.76 67.62 0.36 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.49 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.616 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . . . -104.93 132.4 51.22 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -139.65 150.75 45.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.024 0.44 . . . . 0.0 111.506 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 38.9 t -80.79 106.79 13.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.472 HG21 ' OH ' ' A' ' 37' ' ' TYR . 3.7 tp -129.84 -46.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -167.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.437 ' ND2' HG23 ' A' ' 30' ' ' ILE . 55.7 m-80 -108.17 33.64 4.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.824 0.345 . . . . 0.0 110.854 -175.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.49 -5.98 62.5 Favored Glycine 0 CA--C 1.507 -0.411 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -172.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.819 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 19.4 ptt-85 -140.65 176.88 8.43 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.578 -0.811 . . . . 0.0 109.094 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.6 m -95.14 126.35 40.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.404 0.621 . . . . 0.0 112.278 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.0 m -119.95 132.16 55.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.222 174.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.848 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 38.7 m -100.04 125.59 46.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.299 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' A' ' 30' ' ' ILE . 32.9 m-85 -109.64 91.07 9.75 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.55 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 3.0 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.329 2.686 . . . . 0.0 111.798 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.787 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 1.6 mp . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 121.039 0.447 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -113.06 100.41 8.59 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 170.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.449 ' O ' HG21 ' A' ' 6' ' ' VAL . 67.9 p -69.41 -23.06 63.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.455 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 59.83 32.86 21.52 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 122.094 0.949 . . . . 0.0 109.524 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 4' ' ' THR . 88.3 t -123.78 120.06 58.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.142 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 41.0 mtmt -49.42 139.97 11.09 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.214 0.946 . . . . 0.0 112.224 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 p -94.39 162.28 13.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.1 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.4 m -111.14 30.04 7.25 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.47 158.29 14.86 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.777 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.4 p -63.82 -21.9 66.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.231 0.515 . . . . 0.0 111.447 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.8 m -60.13 -28.75 68.14 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.451 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -72.69 -51.09 20.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.129 0.49 . . . . 0.0 109.99 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -63.48 -45.48 90.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.212 -175.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.78 -15.72 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.163 0.506 . . . . 0.0 111.387 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -102.88 -50.8 3.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.961 0.41 . . . . 0.0 110.423 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 20' ' ' ASP . 3.0 tp -77.95 -22.5 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.74 -17.54 64.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.101 0.477 . . . . 0.0 110.102 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.29 -27.4 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.307 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.52 ' HB3' HD12 ' A' ' 17' ' ' ILE . 24.1 t70 -86.26 -44.84 11.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.246 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -69.32 -49.83 52.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.941 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.64 -111.71 0.33 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.933 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -161.59 12.92 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.447 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.48 HG23 ' HG3' ' A' ' 38' ' ' PRO . 22.9 p -119.95 129.52 54.35 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -165.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.655 ' HD2' ' N ' ' A' ' 26' ' ' GLY . 1.9 ppt_? -84.97 -11.14 56.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.082 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.655 ' N ' ' HD2' ' A' ' 25' ' ' ARG . . . -95.35 100.53 2.56 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.639 -175.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -140.96 142.42 34.34 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.903 0.382 . . . . 0.0 111.025 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -145.48 141.75 28.62 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.9 t -84.88 112.66 20.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.516 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.4 tp -99.07 -63.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.516 ' H ' HG23 ' A' ' 30' ' ' ILE . 23.9 p-10 -105.38 17.1 24.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.419 0.628 . . . . 0.0 110.204 -174.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 104.57 -5.75 44.39 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.598 -176.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 mmt-85 -108.38 172.45 6.83 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 47.9 m -91.2 110.64 21.93 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.903 175.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 84.9 m -117.86 131.36 56.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.223 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.787 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 28.4 m -106.1 134.74 48.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.597 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -118.83 87.88 34.23 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.729 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HG3' HG23 ' A' ' 24' ' ' THR . 8.4 Cg_exo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.723 2.949 . . . . 0.0 112.549 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.81 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 47.5 mm . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 121.027 0.442 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -98.83 109.66 22.38 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.7 p -74.47 -13.68 60.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.861 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 60.0 39.79 19.54 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 109.969 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 69.3 t -115.86 104.53 16.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.237 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 48.1 mtpt -52.76 121.07 6.51 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.969 176.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.5 p -139.67 148.88 43.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.759 -176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 p -94.42 -51.28 4.84 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.15 123.37 7.91 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.761 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.834 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 34.8 m -62.18 -24.21 67.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 111.612 -177.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.467 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 32.8 t -66.19 -30.63 71.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.077 -168.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -69.16 -15.83 63.5 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.129 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HA ' HG23 ' A' ' 17' ' ' ILE . 72.7 m -102.93 -39.94 6.73 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.747 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 1.4 p -58.21 -35.69 54.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.427 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -72.62 -40.59 66.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.774 0.321 . . . . 0.0 111.355 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.419 HG23 ' HA ' ' A' ' 14' ' ' CYS . 4.5 tp -86.39 -32.71 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.0 t -56.61 -26.91 57.01 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.035 0.445 . . . . 0.0 110.399 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 15' ' ' VAL . 78.1 mt -60.28 -41.0 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.408 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -85.1 -23.04 28.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.424 0.63 . . . . 0.0 110.481 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.96 -55.45 5.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.949 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.54 -108.07 0.33 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.505 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -161.21 18.18 0.11 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.975 0.417 . . . . 0.0 110.748 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 36' ' ' CYS . 2.9 t -120.0 162.99 18.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 -173.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.673 ' HD3' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -126.17 2.49 7.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.309 -173.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.05 71.37 0.32 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.76 -174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.747 ' HB3' ' HA ' ' A' ' 15' ' ' VAL . . . -99.05 144.97 27.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.911 0.386 . . . . 0.0 110.188 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -147.78 141.95 26.11 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.926 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.834 ' SG ' ' HA ' ' A' ' 11' ' ' SER . 70.2 m -79.43 100.62 7.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.538 HG23 ' H ' ' A' ' 31' ' ' ASN . 6.1 tp -98.46 -66.09 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.757 -170.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.538 ' H ' HG23 ' A' ' 30' ' ' ILE . 92.4 m-20 -96.64 34.98 1.57 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.28 4.66 89.46 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.402 -174.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.5 mmt85 -128.75 157.96 39.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 m -77.18 112.76 14.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.531 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 61.4 m -116.98 128.06 54.81 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.81 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 46.3 m -99.13 128.02 45.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.346 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -110.95 92.52 15.07 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.183 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 10.2 Cg_exo . . . . . 0 C--O 1.25 1.092 0 C-N-CA 123.227 2.618 . . . . 0.0 111.742 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.707 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 34.0 mm . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.843 0.354 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -90.14 100.34 13.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -72.89 -11.65 60.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.068 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.78 46.1 14.64 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.909 0.861 . . . . 0.0 109.643 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 74.2 t -119.83 103.69 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.416 -173.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 27.0 mtmm -56.07 120.98 8.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.602 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.9 p -133.53 160.72 36.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.344 0.592 . . . . 0.0 112.17 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.8 m -121.8 -0.2 9.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.446 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.75 143.41 10.75 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.248 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 10.7 m -90.56 -26.76 19.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.627 0.251 . . . . 0.0 111.257 -177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 t -60.62 -42.54 97.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.061 -170.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -63.79 -29.18 70.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.772 0.32 . . . . 0.0 110.987 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.524 ' HA ' HG23 ' A' ' 17' ' ' ILE . 98.8 m -85.08 -46.01 11.56 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.658 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 2.6 p -59.71 -33.57 52.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.623 0.249 . . . . 0.0 111.454 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -79.14 -36.49 40.44 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.057 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 20' ' ' ASP . 4.0 tp -85.48 -23.11 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.147 0.499 . . . . 0.0 111.405 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.697 ' SG ' HG23 ' A' ' 24' ' ' THR . 41.8 t -63.3 -20.52 65.55 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.14 0.495 . . . . 0.0 110.106 176.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.8 mt -75.41 -32.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.463 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 17' ' ' ILE . 12.4 t70 -83.89 -43.9 14.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.339 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.52 -38.74 81.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.946 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -123.07 -109.38 0.33 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -162.51 4.62 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.053 0.454 . . . . 0.0 111.152 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.697 HG23 ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -105.76 154.52 20.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.17 0.51 . . . . 0.0 111.415 -170.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.46 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -118.29 16.42 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.808 -168.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.2 55.43 0.74 Allowed Glycine 0 C--O 1.224 -0.503 0 C-N-CA 119.684 -1.246 . . . . 0.0 113.554 -173.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.724 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -97.89 130.51 44.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.278 0.539 . . . . 0.0 111.044 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 84.8 tttt -130.47 140.72 50.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.413 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.0 t -81.69 92.29 6.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 31' ' ' ASN . 5.2 tp -116.96 -58.37 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -168.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.454 ' H ' HG22 ' A' ' 30' ' ' ILE . 4.3 t30 -95.18 40.74 1.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.533 0.682 . . . . 0.0 109.516 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.98 -0.52 72.36 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.142 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 7.3 ptp180 -141.13 165.3 27.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 63.3 m -83.3 106.49 15.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.8 m -100.49 126.72 46.94 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -99.76 122.65 43.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.079 -176.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -106.31 96.15 12.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.569 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 8.2 Cg_exo . . . . . 0 C--O 1.25 1.079 0 C-N-CA 123.727 2.951 . . . . 0.0 112.14 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.764 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 36.6 mt . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 121.253 0.549 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -101.83 122.78 44.63 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.503 ' HG1' ' HB ' ' A' ' 6' ' ' VAL . 17.9 p -78.79 -5.04 52.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.538 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.5 t30 58.71 39.08 24.74 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 122.602 1.192 . . . . 0.0 109.016 -173.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.503 ' HB ' ' HG1' ' A' ' 4' ' ' THR . 66.3 t -129.8 112.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.036 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -63.07 132.63 52.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.6 p -101.53 130.26 47.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.255 0.55 . . . . 0.0 112.114 -169.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -106.6 15.3 25.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.842 0.829 . . . . 0.0 108.783 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.08 137.74 2.28 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.537 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' HG12 ' A' ' 15' ' ' VAL . 19.4 m -70.06 -26.65 64.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.177 0.489 . . . . 0.0 111.641 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -66.42 -43.07 86.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -170.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -33.92 75.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.282 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 10.2 m -67.13 -58.15 5.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.617 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 19' ' ' ILE . 2.4 p -57.55 -35.35 49.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.18 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.41 -52.92 55.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.226 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 20' ' ' ASP . 2.5 tp -81.43 -24.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.129 0.49 . . . . 0.0 111.528 -173.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 20.1 t -63.86 -24.48 67.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.37 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 15' ' ' VAL . 64.7 mt -74.96 -39.95 45.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.692 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.489 ' HB3' HD13 ' A' ' 17' ' ' ILE . 14.4 t70 -76.26 -39.43 54.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.269 0.557 . . . . 0.0 109.792 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -67.46 -56.41 9.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.021 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.441 ' HE2' HG23 ' A' ' 4' ' ' THR . 59.1 m-85 -109.37 -101.87 0.38 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 -172.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -160.39 -15.08 0.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.218 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.446 ' HG1' ' HA ' ' A' ' 38' ' ' PRO . 4.7 t -101.47 163.92 12.02 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.329 -165.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.663 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -137.29 13.03 3.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.535 -167.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.67 79.37 0.37 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.58 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.17 141.16 47.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.024 0.44 . . . . 0.0 111.029 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -127.54 136.35 51.59 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.504 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 43.9 t -79.67 103.3 9.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 31' ' ' ASN . 4.9 tp -127.97 -64.34 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -169.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.495 ' H ' HG22 ' A' ' 30' ' ' ILE . 95.8 m-20 -95.77 33.71 1.62 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.047 0.451 . . . . 0.0 110.899 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.71 -12.86 67.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.716 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -133.48 169.67 16.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.874 0.369 . . . . 0.0 110.579 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 18.8 m -76.31 123.15 25.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.571 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -117.46 120.66 38.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.196 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.764 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 59.9 m -98.99 125.86 44.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.415 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -105.36 92.68 5.97 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.323 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 15.4 Cg_exo . . . . . 0 C--O 1.247 0.947 0 C-N-CA 123.45 2.767 . . . . 0.0 112.145 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 77.3 mt . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.75 0.31 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -108.48 129.23 55.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.495 ' O ' HG21 ' A' ' 6' ' ' VAL . 13.8 p -85.96 -0.03 54.45 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.456 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 62.8 t30 55.29 42.64 30.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 122.413 1.101 . . . . 0.0 109.265 -174.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 4' ' ' THR . 54.2 t -129.89 113.26 26.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.167 -1.378 . . . . 0.0 110.097 -174.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -51.62 138.36 22.99 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.754 0.659 . . . . 0.0 110.146 176.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 p -79.0 134.31 36.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.465 0.65 . . . . 0.0 111.598 -168.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 t -96.76 43.21 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.843 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.63 21.79 7.36 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.367 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.5 p 65.46 -51.41 0.37 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.923 1.289 . . . . 0.0 113.267 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 t -63.22 -36.4 83.52 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.552 0.341 . . . . 0.0 111.877 -173.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -50.84 -45.58 59.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.153 0.501 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 1.5 m -67.49 -44.06 79.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.305 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.564 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 16.2 t -55.82 -40.14 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -74.28 -55.53 5.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.612 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 20' ' ' ASP . 2.8 tp -77.36 -28.0 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -169.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.493 ' SG ' HG22 ' A' ' 24' ' ' THR . 7.8 t -62.49 -26.41 68.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.974 0.416 . . . . 0.0 110.024 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 24' ' ' THR . 59.5 mt -71.74 -44.91 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HB3' HD12 ' A' ' 17' ' ' ILE . 23.3 t70 -68.79 -36.06 77.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.232 0.539 . . . . 0.0 110.425 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.73 -45.32 25.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.101 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -121.81 -114.09 0.32 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.422 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -161.73 92.06 0.85 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.287 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.661 HG21 ' HG3' ' A' ' 38' ' ' PRO . 72.8 p -135.68 153.61 51.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.297 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -117.46 6.25 12.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.059 0.457 . . . . 0.0 109.811 174.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.87 127.96 1.36 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.479 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . . . -128.75 159.35 35.96 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -149.54 155.76 40.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.196 0.522 . . . . 0.0 111.326 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.1 t -96.61 100.23 11.81 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 tp -99.52 -50.9 10.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.729 -170.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -115.65 19.7 15.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.781 0.8 . . . . 0.0 109.709 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.25 -7.37 32.56 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.709 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.457 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 10.7 ptt180 -131.31 170.94 13.94 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.585 -0.362 . . . . 0.0 110.888 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 32.7 m -75.73 123.25 25.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.538 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.5 m -126.16 122.2 35.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.486 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.668 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 34.2 m -98.07 136.46 38.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.303 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -117.48 84.23 18.3 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.686 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.661 ' HG3' HG21 ' A' ' 24' ' ' THR . 11.4 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.268 2.646 . . . . 0.0 111.655 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.774 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 92.6 mt . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.634 0.254 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -98.9 131.67 44.81 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -79.7 -22.17 43.72 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.64 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 4.8 t-20 67.58 38.7 3.0 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.092 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.14 128.21 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.994 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 43.4 mtmt -64.99 145.17 56.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.6 p -114.57 152.99 30.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 p -78.69 -39.48 36.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.623 0.725 . . . . 0.0 109.681 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.73 169.08 31.17 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.498 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.582 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 15.8 p -57.82 -28.43 64.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.937 0.399 . . . . 0.0 111.533 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.558 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 47.9 t -73.78 -8.33 55.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.229 -174.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -65.86 -53.93 33.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.918 0.389 . . . . 0.0 110.937 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 1.2 m -77.17 -40.93 43.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' CG1' ' HA ' ' A' ' 12' ' ' SER . 6.0 p -57.71 -26.9 28.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -172.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.731 ' HZ1' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -87.61 -40.89 13.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.288 178.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.645 HD11 ' HB3' ' A' ' 20' ' ' ASP . 4.5 tp -85.14 -27.17 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.231 0.539 . . . . 0.0 111.738 -172.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.7 t -60.75 -21.43 62.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.358 0.599 . . . . 0.0 109.826 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.2 mt -79.53 -29.96 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.075 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.645 ' HB3' HD11 ' A' ' 17' ' ' ILE . 30.3 t70 -85.32 -29.49 24.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.681 0.753 . . . . 0.0 109.945 -174.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 55.1 mtp180 -92.03 -43.86 9.18 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.226 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -110.05 -111.5 0.32 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.142 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -162.13 6.41 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 t -115.69 142.52 46.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.356 0.598 . . . . 0.0 111.797 -172.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -98.29 7.48 46.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.284 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.59 103.25 1.62 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.11 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -142.48 140.04 31.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.892 0.377 . . . . 0.0 110.762 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -138.01 142.7 40.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.204 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 82.1 m -80.2 133.42 36.02 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.2 tp -121.77 -55.79 3.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.947 -171.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 33' ' ' ARG . 15.8 t-20 -129.95 61.93 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.74 -26.07 2.05 Favored Glycine 0 CA--C 1.517 0.202 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.413 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.64 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 37.8 ttp180 -109.25 149.01 30.05 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 8.4 p -95.98 141.86 28.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 0.0 111.237 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.6 m -131.18 145.05 51.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.065 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.774 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 39.8 m -97.75 123.81 41.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.905 0.383 . . . . 0.0 110.306 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -116.6 85.87 17.55 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.161 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo . . . . . 0 C--O 1.248 1.014 0 C-N-CA 122.995 2.463 . . . . 0.0 111.521 176.812 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.838 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 77.9 mt -83.88 101.81 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.03 0.443 . . . . 0.0 110.94 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -116.37 101.54 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.712 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.417 ' HG1' ' CG2' ' A' ' 6' ' ' VAL . 18.4 p -90.11 3.16 54.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.36 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t30 57.82 51.75 8.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 122.193 0.997 . . . . 0.0 109.693 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 85.9 t -124.57 118.6 53.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.705 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.17 148.29 48.46 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.506 0.503 . . . . 0.0 109.725 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.422 ' C ' ' H ' ' A' ' 10' ' ' GLY . 29.4 p -86.74 111.42 20.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.492 0.663 . . . . 0.0 111.536 -174.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -86.43 32.91 0.63 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 8' ' ' CYS . . . 113.18 128.83 4.94 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.53 -170.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 m -61.07 -19.02 60.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.071 0.436 . . . . 0.0 110.83 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.444 ' HA ' HG13 ' A' ' 15' ' ' VAL . 13.3 m -81.7 -5.84 58.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.763 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.568 ' HB2' ' HZ3' ' A' ' 13' ' ' LYS . 3.6 ttmp? -82.97 -51.19 7.8 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -62.39 -46.96 86.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.986 -178.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.444 HG13 ' HA ' ' A' ' 12' ' ' SER . 7.1 p -57.67 -27.99 31.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.675 0.274 . . . . 0.0 111.524 -175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -88.97 -43.84 10.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.731 0.301 . . . . 0.0 111.174 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 13' ' ' LYS . 3.1 tp -82.29 -29.69 9.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.0 0.428 . . . . 0.0 112.031 -173.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.633 ' HA ' ' HD2' ' A' ' 21' ' ' ARG . 7.7 t -65.47 -20.24 66.27 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.061 0.458 . . . . 0.0 110.056 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 25' ' ' ARG . 66.5 mt -64.74 -39.46 85.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.312 173.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.63 -23.53 49.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.063 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.633 ' HD2' ' HA ' ' A' ' 18' ' ' CYS . 99.7 mtt180 -67.41 -67.43 0.46 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.267 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.11 -94.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.002 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -160.08 18.4 0.15 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 -174.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.497 ' HB ' ' HG3' ' A' ' 38' ' ' PRO . 8.4 t -103.73 161.1 14.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.05 0.452 . . . . 0.0 110.855 -173.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.422 ' HA ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -124.39 10.15 8.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.465 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.57 119.29 1.46 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.04 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -141.16 144.56 34.89 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -141.64 145.59 35.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.994 0.426 . . . . 0.0 110.918 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 29.3 t -86.18 110.24 19.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -116.85 -46.57 3.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.474 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.505 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 27.3 p-10 -108.25 20.04 19.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.236 0.541 . . . . 0.0 110.603 -176.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.86 -6.07 54.15 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.057 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 11.4 ptp180 -130.95 167.99 18.08 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.9 m -89.98 113.08 24.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.8 m -112.55 135.67 53.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.573 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.838 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 17.7 m -99.7 130.78 45.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.798 0.332 . . . . 0.0 110.284 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -120.78 86.22 40.62 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.612 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 2.9 Cg_exo . . . . . 0 C--O 1.251 1.17 0 C-N-CA 123.149 2.566 . . . . 0.0 111.969 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.269 . . . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.3 mt -125.07 124.41 67.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.141 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -103.46 125.49 50.07 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.7 p -75.63 -22.16 57.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.344 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 65.67 36.86 6.12 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.504 1.145 . . . . 0.0 108.65 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 3.2 t -135.8 114.47 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 112.929 -1.942 . . . . 0.0 110.222 -172.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 143.47 56.57 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.041 0.448 . . . . 0.0 110.319 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 p -122.22 160.6 24.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.644 -172.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 p -85.93 -48.65 8.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.276 172.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.54 162.55 25.46 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.788 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 20.5 m -62.13 -18.78 61.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.2 0.5 . . . . 0.0 111.346 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.5 p -64.68 -15.35 61.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.193 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -62.18 -55.2 31.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.921 0.391 . . . . 0.0 111.441 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.521 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 9.6 m -82.51 -41.67 19.41 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' N ' ' HB1' ' A' ' 27' ' ' ALA . 2.5 p -51.22 -33.64 13.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -172.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -46.43 10.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.753 0.311 . . . . 0.0 110.735 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.644 HD11 ' HB3' ' A' ' 20' ' ' ASP . 3.5 tp -77.43 -29.55 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 111.937 -171.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -64.33 -15.91 61.21 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.776 178.015 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.9 mt -85.65 -25.53 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.153 0.502 . . . . 0.0 110.216 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.644 ' HB3' HD11 ' A' ' 17' ' ' ILE . 13.4 t70 -85.55 -32.89 21.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.473 0.654 . . . . 0.0 109.904 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.565 ' HD2' HG13 ' A' ' 17' ' ' ILE . 58.2 mtp180 -89.25 -41.92 11.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.728 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.27 -116.53 0.29 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -164.4 101.95 0.83 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.605 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.53 HG23 ' HB3' ' A' ' 36' ' ' CYS . 70.0 p -133.92 163.0 30.49 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.001 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.35 -39.22 7.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.61 150.86 23.15 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.291 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' HB1' ' N ' ' A' ' 15' ' ' VAL . . . -141.31 137.21 32.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -126.39 139.28 53.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.998 0.428 . . . . 0.0 111.099 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.788 ' SG ' ' HA ' ' A' ' 11' ' ' SER . 56.0 m -79.83 107.05 12.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.51 173.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.5 tp -117.58 -45.25 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.05 -171.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -97.82 16.34 21.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.139 0.971 . . . . 0.0 109.873 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.65 -13.88 64.82 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 14.5 ptt180 -122.53 165.34 16.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.286 -0.957 . . . . 0.0 108.658 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.589 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 2.0 p -96.83 119.38 35.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.288 0.566 . . . . 0.0 111.715 -172.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.0 m -99.55 131.87 45.26 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.558 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.565 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 29.5 m -98.5 135.78 39.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -113.91 90.63 19.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.105 0.479 . . . . 0.0 111.039 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 32.8 Cg_endo . . . . . 0 N--CA 1.444 -1.398 0 C-N-CA 124.395 3.397 . . . . 0.0 111.9 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.292 . . . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.842 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 78.1 mt -91.38 102.43 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.46 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -122.65 122.57 39.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.079 0.466 . . . . 0.0 110.264 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 p -97.17 1.16 49.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.892 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.683 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 37.4 t30 52.98 71.71 0.47 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.966 0.888 . . . . 0.0 110.119 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.2 t -134.68 110.06 12.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.514 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HE3' ' HB3' ' A' ' 7' ' ' LYS . 23.8 mmmt -48.82 117.73 2.21 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.692 0.62 . . . . 0.0 110.232 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.1 p -83.0 145.84 29.1 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.108 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p -103.28 28.35 6.45 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.876 171.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.13 -113.54 0.94 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.782 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.1 p -164.38 -27.66 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.892 0.377 . . . . 0.0 110.385 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.41 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 10.7 p -60.59 -14.86 22.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.856 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.434 ' O ' HG21 ' A' ' 17' ' ' ILE . 4.7 tmtm? -69.12 -61.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.524 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -63.61 -48.72 76.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.45 -174.474 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 6.0 p -54.15 -33.51 25.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -86.36 -52.04 5.86 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.162 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.6 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 4.1 tp -72.03 -32.05 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -172.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 t -60.77 -24.19 65.58 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.977 0.417 . . . . 0.0 110.356 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.8 mt -69.72 -39.44 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.809 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.576 ' HB2' HD12 ' A' ' 17' ' ' ILE . 16.4 m-20 -77.41 -14.08 59.78 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.097 0.475 . . . . 0.0 110.65 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.6 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 49.0 mtm180 -98.65 -47.6 5.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.845 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -115.1 -109.11 0.36 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -161.85 15.57 0.09 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.067 0.461 . . . . 0.0 110.881 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 t -104.54 139.84 38.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.994 0.426 . . . . 0.0 110.821 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.568 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -101.67 -2.65 29.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.643 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.9 97.87 0.84 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.994 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HB3' ' HB2' ' A' ' 14' ' ' CYS . . . -131.88 131.35 42.68 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 28' ' ' LYS . 26.4 ttpt -133.36 148.93 51.87 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.116 -176.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 15.0 t -85.87 127.16 34.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 172.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.533 HG23 ' H ' ' A' ' 31' ' ' ASN . 4.3 tp -112.75 -71.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.729 -176.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.533 ' H ' HG23 ' A' ' 30' ' ' ILE . 21.6 t-20 -98.27 40.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.519 0.676 . . . . 0.0 109.922 -176.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.64 3.79 70.91 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.259 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.683 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 5.9 ptp180 -134.19 157.08 47.15 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 1.5 m -89.08 120.46 30.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.998 0.428 . . . . 0.0 111.499 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.0 m -123.29 139.91 53.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.726 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.842 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 32.8 m -99.07 132.29 44.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -119.93 83.76 30.89 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.136 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo . . . . . 0 C--O 1.246 0.92 0 C-N-CA 122.838 2.359 . . . . 0.0 111.711 177.491 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.277 . . . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.848 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 87.5 mt -87.28 84.84 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.406 0.622 . . . . 0.0 110.116 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -90.82 106.71 18.7 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.423 ' OG1' ' HB ' ' A' ' 6' ' ' VAL . 24.8 p -75.37 -24.74 57.31 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.423 -173.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.819 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 66.2 t30 67.26 40.37 2.79 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 122.832 1.301 . . . . 0.0 107.664 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 5.1 t -124.04 126.83 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 112.999 -1.91 . . . . 0.0 109.747 -170.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -60.55 144.16 52.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.345 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.651 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 4.1 p -104.7 129.48 52.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.15 0.5 . . . . 0.0 111.905 -176.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 m -96.46 21.46 9.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.639 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.76 34.66 0.9 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.038 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.465 ' O ' HG12 ' A' ' 15' ' ' VAL . 68.7 m 71.46 -37.64 0.4 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.479 0.712 . . . . 0.0 112.9 175.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.561 ' HA ' HG12 ' A' ' 15' ' ' VAL . 22.0 t -62.4 -19.96 63.97 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.455 0.645 . . . . 0.0 109.909 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -57.22 -43.23 82.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.706 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -97.52 -49.24 4.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.283 -175.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 12' ' ' SER . 14.9 p -62.11 -8.95 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.367 0.603 . . . . 0.0 111.666 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.489 ' HB3' ' HZ1' ' A' ' 16' ' ' LYS . 7.6 ttpm? -96.8 -51.49 4.26 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.997 -0.439 . . . . 0.0 110.703 174.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.619 HD12 ' HB3' ' A' ' 20' ' ' ASP . 1.7 tp -85.32 -32.85 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.1 t -62.85 -25.81 68.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.45 0.643 . . . . 0.0 109.704 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.653 HG13 ' O ' ' A' ' 24' ' ' THR . 1.7 mp -77.63 -33.4 19.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.404 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.619 ' HB3' HD12 ' A' ' 17' ' ' ILE . 8.5 t70 -76.17 -35.83 58.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.363 0.602 . . . . 0.0 109.64 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -75.35 -52.56 10.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.254 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -111.93 -113.57 0.33 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.113 0.483 . . . . 0.0 112.246 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -159.04 19.73 0.19 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.52 -170.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.653 ' O ' HG13 ' A' ' 19' ' ' ILE . 9.0 t -100.77 171.48 7.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.145 -174.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.5 -1.35 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.031 0.443 . . . . 0.0 110.347 173.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.76 67.62 0.36 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.49 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.616 ' HB2' ' HB2' ' A' ' 14' ' ' CYS . . . -104.93 132.4 51.22 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -139.65 150.75 45.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.024 0.44 . . . . 0.0 111.506 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 38.9 t -80.79 106.79 13.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.472 HG21 ' OH ' ' A' ' 37' ' ' TYR . 3.7 tp -129.84 -46.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -167.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.437 ' ND2' HG23 ' A' ' 30' ' ' ILE . 55.7 m-80 -108.17 33.64 4.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.824 0.345 . . . . 0.0 110.854 -175.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.49 -5.98 62.5 Favored Glycine 0 CA--C 1.507 -0.411 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -172.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.819 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 19.4 ptt-85 -140.65 176.88 8.43 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.578 -0.811 . . . . 0.0 109.094 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.6 m -95.14 126.35 40.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.404 0.621 . . . . 0.0 112.278 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.0 m -119.95 132.16 55.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.222 174.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.848 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 38.7 m -100.04 125.59 46.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.299 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.472 ' OH ' HG21 ' A' ' 30' ' ' ILE . 32.9 m-85 -109.64 91.07 9.75 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.55 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 3.0 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.329 2.686 . . . . 0.0 111.798 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.278 . . . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.787 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 1.6 mp -68.19 110.09 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.981 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -113.06 100.41 8.59 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 170.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.449 ' O ' HG21 ' A' ' 6' ' ' VAL . 67.9 p -69.41 -23.06 63.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.455 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 59.83 32.86 21.52 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 122.094 0.949 . . . . 0.0 109.524 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 4' ' ' THR . 88.3 t -123.78 120.06 58.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.142 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 41.0 mtmt -49.42 139.97 11.09 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.214 0.946 . . . . 0.0 112.224 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 p -94.39 162.28 13.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.1 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.4 m -111.14 30.04 7.25 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.47 158.29 14.86 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.777 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.4 p -63.82 -21.9 66.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.231 0.515 . . . . 0.0 111.447 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.8 m -60.13 -28.75 68.14 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.451 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -72.69 -51.09 20.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.129 0.49 . . . . 0.0 109.99 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -63.48 -45.48 90.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.212 -175.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.3 p -62.78 -15.72 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.163 0.506 . . . . 0.0 111.387 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -102.88 -50.8 3.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.961 0.41 . . . . 0.0 110.423 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 20' ' ' ASP . 3.0 tp -77.95 -22.5 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.74 -17.54 64.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.101 0.477 . . . . 0.0 110.102 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.29 -27.4 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.307 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.52 ' HB3' HD12 ' A' ' 17' ' ' ILE . 24.1 t70 -86.26 -44.84 11.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.246 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -69.32 -49.83 52.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.941 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.64 -111.71 0.33 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.933 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -161.59 12.92 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.447 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.48 HG23 ' HG3' ' A' ' 38' ' ' PRO . 22.9 p -119.95 129.52 54.35 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -165.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.655 ' HD2' ' N ' ' A' ' 26' ' ' GLY . 1.9 ppt_? -84.97 -11.14 56.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.082 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.655 ' N ' ' HD2' ' A' ' 25' ' ' ARG . . . -95.35 100.53 2.56 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.639 -175.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -140.96 142.42 34.34 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.903 0.382 . . . . 0.0 111.025 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -145.48 141.75 28.62 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.9 t -84.88 112.66 20.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.516 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.4 tp -99.07 -63.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.516 ' H ' HG23 ' A' ' 30' ' ' ILE . 23.9 p-10 -105.38 17.1 24.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.419 0.628 . . . . 0.0 110.204 -174.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.533 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 104.57 -5.75 44.39 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.598 -176.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 mmt-85 -108.38 172.45 6.83 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 47.9 m -91.2 110.64 21.93 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.903 175.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 84.9 m -117.86 131.36 56.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.223 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.787 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 28.4 m -106.1 134.74 48.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.597 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -118.83 87.88 34.23 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.729 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HG3' HG23 ' A' ' 24' ' ' THR . 8.4 Cg_exo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.723 2.949 . . . . 0.0 112.549 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.281 . . . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.81 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 47.5 mm -82.65 86.98 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.027 0.442 . . . . 0.0 110.27 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -98.83 109.66 22.38 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.7 p -74.47 -13.68 60.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.861 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 60.0 39.79 19.54 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 109.969 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 69.3 t -115.86 104.53 16.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.237 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 48.1 mtpt -52.76 121.07 6.51 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.969 176.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.5 p -139.67 148.88 43.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.759 -176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 p -94.42 -51.28 4.84 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.15 123.37 7.91 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.761 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.834 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 34.8 m -62.18 -24.21 67.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 111.612 -177.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.467 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 32.8 t -66.19 -30.63 71.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.077 -168.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -69.16 -15.83 63.5 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.129 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.419 ' HA ' HG23 ' A' ' 17' ' ' ILE . 72.7 m -102.93 -39.94 6.73 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.747 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 1.4 p -58.21 -35.69 54.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.427 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -72.62 -40.59 66.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.774 0.321 . . . . 0.0 111.355 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.419 HG23 ' HA ' ' A' ' 14' ' ' CYS . 4.5 tp -86.39 -32.71 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.0 t -56.61 -26.91 57.01 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.035 0.445 . . . . 0.0 110.399 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 15' ' ' VAL . 78.1 mt -60.28 -41.0 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.408 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -85.1 -23.04 28.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.424 0.63 . . . . 0.0 110.481 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.96 -55.45 5.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.949 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.54 -108.07 0.33 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.505 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -161.21 18.18 0.11 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.975 0.417 . . . . 0.0 110.748 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 36' ' ' CYS . 2.9 t -120.0 162.99 18.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 -173.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.673 ' HD3' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -126.17 2.49 7.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.309 -173.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.05 71.37 0.32 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.76 -174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.747 ' HB3' ' HA ' ' A' ' 15' ' ' VAL . . . -99.05 144.97 27.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.911 0.386 . . . . 0.0 110.188 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -147.78 141.95 26.11 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.926 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.834 ' SG ' ' HA ' ' A' ' 11' ' ' SER . 70.2 m -79.43 100.62 7.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.538 HG23 ' H ' ' A' ' 31' ' ' ASN . 6.1 tp -98.46 -66.09 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.757 -170.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.538 ' H ' HG23 ' A' ' 30' ' ' ILE . 92.4 m-20 -96.64 34.98 1.57 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.28 4.66 89.46 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.402 -174.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.5 mmt85 -128.75 157.96 39.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 m -77.18 112.76 14.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.531 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 61.4 m -116.98 128.06 54.81 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.81 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 46.3 m -99.13 128.02 45.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.346 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -110.95 92.52 15.07 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.183 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 10.2 Cg_exo . . . . . 0 C--O 1.25 1.092 0 C-N-CA 123.227 2.618 . . . . 0.0 111.742 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.278 . . . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.707 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 34.0 mm -78.17 100.13 3.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.23 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -90.14 100.34 13.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -72.89 -11.65 60.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.068 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.78 46.1 14.64 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.909 0.861 . . . . 0.0 109.643 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 74.2 t -119.83 103.69 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.416 -173.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 27.0 mtmm -56.07 120.98 8.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.602 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.9 p -133.53 160.72 36.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.344 0.592 . . . . 0.0 112.17 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.8 m -121.8 -0.2 9.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.446 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.75 143.41 10.75 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.248 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' A' ' 28' ' ' LYS . 10.7 m -90.56 -26.76 19.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.627 0.251 . . . . 0.0 111.257 -177.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 t -60.62 -42.54 97.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.061 -170.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -63.79 -29.18 70.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.772 0.32 . . . . 0.0 110.987 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.524 ' HA ' HG23 ' A' ' 17' ' ' ILE . 98.8 m -85.08 -46.01 11.56 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.658 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 2.6 p -59.71 -33.57 52.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.623 0.249 . . . . 0.0 111.454 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -79.14 -36.49 40.44 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.057 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 20' ' ' ASP . 4.0 tp -85.48 -23.11 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.147 0.499 . . . . 0.0 111.405 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.697 ' SG ' HG23 ' A' ' 24' ' ' THR . 41.8 t -63.3 -20.52 65.55 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.14 0.495 . . . . 0.0 110.106 176.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.8 mt -75.41 -32.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.463 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 17' ' ' ILE . 12.4 t70 -83.89 -43.9 14.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.339 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.52 -38.74 81.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.946 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -123.07 -109.38 0.33 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -162.51 4.62 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.053 0.454 . . . . 0.0 111.152 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.697 HG23 ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -105.76 154.52 20.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.17 0.51 . . . . 0.0 111.415 -170.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.46 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -118.29 16.42 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.808 -168.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.2 55.43 0.74 Allowed Glycine 0 C--O 1.224 -0.503 0 C-N-CA 119.684 -1.246 . . . . 0.0 113.554 -173.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.724 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -97.89 130.51 44.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.278 0.539 . . . . 0.0 111.044 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 84.8 tttt -130.47 140.72 50.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.413 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.0 t -81.69 92.29 6.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.454 HG22 ' H ' ' A' ' 31' ' ' ASN . 5.2 tp -116.96 -58.37 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -168.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.454 ' H ' HG22 ' A' ' 30' ' ' ILE . 4.3 t30 -95.18 40.74 1.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.533 0.682 . . . . 0.0 109.516 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.98 -0.52 72.36 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.142 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 7.3 ptp180 -141.13 165.3 27.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 63.3 m -83.3 106.49 15.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.8 m -100.49 126.72 46.94 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.724 ' SG ' ' HB2' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -99.76 122.65 43.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.079 -176.492 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -106.31 96.15 12.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.569 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 8.2 Cg_exo . . . . . 0 C--O 1.25 1.079 0 C-N-CA 123.727 2.951 . . . . 0.0 112.14 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.287 . . . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.764 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 36.6 mt -85.21 104.74 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.253 0.549 . . . . 0.0 110.853 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -101.83 122.78 44.63 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.503 ' HG1' ' HB ' ' A' ' 6' ' ' VAL . 17.9 p -78.79 -5.04 52.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.538 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.5 t30 58.71 39.08 24.74 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 122.602 1.192 . . . . 0.0 109.016 -173.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.503 ' HB ' ' HG1' ' A' ' 4' ' ' THR . 66.3 t -129.8 112.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.036 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -63.07 132.63 52.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.6 p -101.53 130.26 47.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.255 0.55 . . . . 0.0 112.114 -169.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -106.6 15.3 25.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.842 0.829 . . . . 0.0 108.783 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.08 137.74 2.28 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.537 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' HG12 ' A' ' 15' ' ' VAL . 19.4 m -70.06 -26.65 64.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.177 0.489 . . . . 0.0 111.641 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -66.42 -43.07 86.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -170.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -33.92 75.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.282 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 10.2 m -67.13 -58.15 5.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.617 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 19' ' ' ILE . 2.4 p -57.55 -35.35 49.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.18 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.41 -52.92 55.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.226 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.489 HD13 ' HB3' ' A' ' 20' ' ' ASP . 2.5 tp -81.43 -24.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.129 0.49 . . . . 0.0 111.528 -173.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 20.1 t -63.86 -24.48 67.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.37 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.553 HG13 ' O ' ' A' ' 15' ' ' VAL . 64.7 mt -74.96 -39.95 45.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.692 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.489 ' HB3' HD13 ' A' ' 17' ' ' ILE . 14.4 t70 -76.26 -39.43 54.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.269 0.557 . . . . 0.0 109.792 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -67.46 -56.41 9.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.021 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.441 ' HE2' HG23 ' A' ' 4' ' ' THR . 59.1 m-85 -109.37 -101.87 0.38 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 -172.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -160.39 -15.08 0.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.218 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.446 ' HG1' ' HA ' ' A' ' 38' ' ' PRO . 4.7 t -101.47 163.92 12.02 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.329 -165.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.663 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -137.29 13.03 3.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.535 -167.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.67 79.37 0.37 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.58 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.17 141.16 47.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.024 0.44 . . . . 0.0 111.029 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -127.54 136.35 51.59 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.504 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 43.9 t -79.67 103.3 9.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 31' ' ' ASN . 4.9 tp -127.97 -64.34 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -169.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.495 ' H ' HG22 ' A' ' 30' ' ' ILE . 95.8 m-20 -95.77 33.71 1.62 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.047 0.451 . . . . 0.0 110.899 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.71 -12.86 67.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.716 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -133.48 169.67 16.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.874 0.369 . . . . 0.0 110.579 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 18.8 m -76.31 123.15 25.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.571 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -117.46 120.66 38.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.196 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.764 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 59.9 m -98.99 125.86 44.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.415 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -105.36 92.68 5.97 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.323 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 15.4 Cg_exo . . . . . 0 C--O 1.247 0.947 0 C-N-CA 123.45 2.767 . . . . 0.0 112.145 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.309 . . . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.668 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 77.3 mt -82.54 98.07 4.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.75 0.31 . . . . 0.0 110.658 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -108.48 129.23 55.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.495 ' O ' HG21 ' A' ' 6' ' ' VAL . 13.8 p -85.96 -0.03 54.45 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.456 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.457 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 62.8 t30 55.29 42.64 30.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 122.413 1.101 . . . . 0.0 109.265 -174.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 4' ' ' THR . 54.2 t -129.89 113.26 26.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.167 -1.378 . . . . 0.0 110.097 -174.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -51.62 138.36 22.99 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.754 0.659 . . . . 0.0 110.146 176.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 p -79.0 134.31 36.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.465 0.65 . . . . 0.0 111.598 -168.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 t -96.76 43.21 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.843 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.63 21.79 7.36 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.367 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 91.5 p 65.46 -51.41 0.37 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.923 1.289 . . . . 0.0 113.267 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 t -63.22 -36.4 83.52 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.552 0.341 . . . . 0.0 111.877 -173.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -50.84 -45.58 59.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.153 0.501 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 1.5 m -67.49 -44.06 79.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.305 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.564 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 16.2 t -55.82 -40.14 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -74.28 -55.53 5.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.612 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.479 HD12 ' HB3' ' A' ' 20' ' ' ASP . 2.8 tp -77.36 -28.0 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -169.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' SG ' HG22 ' A' ' 24' ' ' THR . 7.8 t -62.49 -26.41 68.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.974 0.416 . . . . 0.0 110.024 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 24' ' ' THR . 59.5 mt -71.74 -44.91 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.479 ' HB3' HD12 ' A' ' 17' ' ' ILE . 23.3 t70 -68.79 -36.06 77.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.232 0.539 . . . . 0.0 110.425 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.73 -45.32 25.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.101 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -121.81 -114.09 0.32 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.422 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -161.73 92.06 0.85 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.287 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.661 HG21 ' HG3' ' A' ' 38' ' ' PRO . 72.8 p -135.68 153.61 51.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.297 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -117.46 6.25 12.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.059 0.457 . . . . 0.0 109.811 174.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.87 127.96 1.36 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.479 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB2' ' HA ' ' A' ' 15' ' ' VAL . . . -128.75 159.35 35.96 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -149.54 155.76 40.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.196 0.522 . . . . 0.0 111.326 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.1 t -96.61 100.23 11.81 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 tp -99.52 -50.9 10.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.729 -170.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -115.65 19.7 15.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.781 0.8 . . . . 0.0 109.709 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.25 -7.37 32.56 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.709 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.457 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 10.7 ptt180 -131.31 170.94 13.94 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.585 -0.362 . . . . 0.0 110.888 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.533 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 32.7 m -75.73 123.25 25.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.538 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.5 m -126.16 122.2 35.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.486 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.668 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 34.2 m -98.07 136.46 38.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.303 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -117.48 84.23 18.3 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.686 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.661 ' HG3' HG21 ' A' ' 24' ' ' THR . 11.4 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.268 2.646 . . . . 0.0 111.655 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.28 . . . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.774 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 92.6 mt -99.8 115.55 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.71 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -98.9 131.67 44.81 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -79.7 -22.17 43.72 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.64 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 4.8 t-20 67.58 38.7 3.0 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.092 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.14 128.21 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.994 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 43.4 mtmt -64.99 145.17 56.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.6 p -114.57 152.99 30.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 p -78.69 -39.48 36.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.623 0.725 . . . . 0.0 109.681 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.73 169.08 31.17 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.498 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.582 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 15.8 p -57.82 -28.43 64.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.937 0.399 . . . . 0.0 111.533 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.558 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 47.9 t -73.78 -8.33 55.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.229 -174.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -65.86 -53.93 33.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.918 0.389 . . . . 0.0 110.937 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 1.2 m -77.17 -40.93 43.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' CG1' ' HA ' ' A' ' 12' ' ' SER . 6.0 p -57.71 -26.9 28.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -172.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.731 ' HZ1' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -87.61 -40.89 13.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.288 178.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.645 HD11 ' HB3' ' A' ' 20' ' ' ASP . 4.5 tp -85.14 -27.17 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.231 0.539 . . . . 0.0 111.738 -172.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.7 t -60.75 -21.43 62.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.358 0.599 . . . . 0.0 109.826 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.2 mt -79.53 -29.96 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.075 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.645 ' HB3' HD11 ' A' ' 17' ' ' ILE . 30.3 t70 -85.32 -29.49 24.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.681 0.753 . . . . 0.0 109.945 -174.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 55.1 mtp180 -92.03 -43.86 9.18 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.226 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -110.05 -111.5 0.32 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.142 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -162.13 6.41 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 t -115.69 142.52 46.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.356 0.598 . . . . 0.0 111.797 -172.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -98.29 7.48 46.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.284 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.59 103.25 1.62 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.11 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -142.48 140.04 31.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.892 0.377 . . . . 0.0 110.762 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -138.01 142.7 40.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.204 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 82.1 m -80.2 133.42 36.02 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.2 tp -121.77 -55.79 3.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.947 -171.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.436 ' C ' ' H ' ' A' ' 33' ' ' ARG . 15.8 t-20 -129.95 61.93 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.74 -26.07 2.05 Favored Glycine 0 CA--C 1.517 0.202 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.413 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.64 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 37.8 ttp180 -109.25 149.01 30.05 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.622 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 8.4 p -95.98 141.86 28.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 0.0 111.237 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.6 m -131.18 145.05 51.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.065 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.774 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 39.8 m -97.75 123.81 41.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.905 0.383 . . . . 0.0 110.306 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -116.6 85.87 17.55 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.161 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo . . . . . 0 C--O 1.248 1.014 0 C-N-CA 122.995 2.463 . . . . 0.0 111.521 176.812 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.862 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 77.9 mt . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.03 0.443 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -116.37 101.54 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.712 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 p -90.11 3.16 54.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.36 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t30 57.82 51.75 8.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 122.193 0.997 . . . . 0.0 109.693 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 85.9 t -124.57 118.6 53.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.705 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.17 148.29 48.46 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.506 0.503 . . . . 0.0 109.725 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.4 p -86.74 111.42 20.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.492 0.663 . . . . 0.0 111.536 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -86.43 32.91 0.63 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.18 128.83 4.94 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.53 -170.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 m -61.07 -19.02 60.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.071 0.436 . . . . 0.0 110.83 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.472 ' HA ' HG12 ' A' ' 15' ' ' VAL . 13.3 m -81.7 -5.84 58.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.763 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 17' ' ' ILE . 3.6 ttmp? -82.97 -51.19 7.8 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -62.39 -46.96 86.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.986 -178.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 12' ' ' SER . 7.1 p -57.67 -27.99 31.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.675 0.274 . . . . 0.0 111.524 -175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -88.97 -43.84 10.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.731 0.301 . . . . 0.0 111.174 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 14' ' ' CYS . 3.1 tp -82.29 -29.69 9.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.0 0.428 . . . . 0.0 112.031 -173.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.635 ' HA ' ' HD2' ' A' ' 21' ' ' ARG . 7.7 t -65.47 -20.24 66.27 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.061 0.458 . . . . 0.0 110.056 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 25' ' ' ARG . 66.5 mt -64.74 -39.46 85.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.312 173.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.63 -23.53 49.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.063 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.635 ' HD2' ' HA ' ' A' ' 18' ' ' CYS . 99.7 mtt180 -67.41 -67.43 0.46 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.267 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.11 -94.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.002 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -160.08 18.4 0.15 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 -174.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' A' ' 38' ' ' PRO . 8.4 t -103.73 161.1 14.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.05 0.452 . . . . 0.0 110.855 -173.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HA ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -124.39 10.15 8.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.465 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.57 119.29 1.46 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.04 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -141.16 144.56 34.89 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -141.64 145.59 35.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.994 0.426 . . . . 0.0 110.918 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 29.3 t -86.18 110.24 19.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -116.85 -46.57 3.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.474 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.527 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 27.3 p-10 -108.25 20.04 19.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.236 0.541 . . . . 0.0 110.603 -176.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.86 -6.07 54.15 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.057 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.527 ' HG2' ' OD1' ' A' ' 31' ' ' ASN . 11.4 ptp180 -130.95 167.99 18.08 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 14.9 m -89.98 113.08 24.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.8 m -112.55 135.67 53.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.573 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.862 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 17.7 m -99.7 130.78 45.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.798 0.332 . . . . 0.0 110.284 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -120.78 86.22 40.62 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.612 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 2.9 Cg_exo . . . . . 0 C--O 1.251 1.17 0 C-N-CA 123.149 2.566 . . . . 0.0 111.969 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.3 mt . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -103.46 125.49 50.07 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.7 p -75.63 -22.16 57.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.344 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 65.67 36.86 6.12 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.504 1.145 . . . . 0.0 108.65 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 3.2 t -135.8 114.47 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 112.929 -1.942 . . . . 0.0 110.222 -172.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 143.47 56.57 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.041 0.448 . . . . 0.0 110.319 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 p -122.22 160.6 24.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.644 -172.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 p -85.93 -48.65 8.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.276 172.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.54 162.55 25.46 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.781 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 20.5 m -62.13 -18.78 61.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.2 0.5 . . . . 0.0 111.346 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.419 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 15.5 p -64.68 -15.35 61.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.193 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -62.18 -55.2 31.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.921 0.391 . . . . 0.0 111.441 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.543 ' HA ' HG22 ' A' ' 17' ' ' ILE . 9.6 m -82.51 -41.67 19.41 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.433 ' N ' ' HB3' ' A' ' 27' ' ' ALA . 2.5 p -51.22 -33.64 13.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -172.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -46.43 10.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.753 0.311 . . . . 0.0 110.735 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 20' ' ' ASP . 3.5 tp -77.43 -29.55 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 111.937 -171.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -64.33 -15.91 61.21 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.776 178.015 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.9 mt -85.65 -25.53 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.153 0.502 . . . . 0.0 110.216 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.679 ' HB3' HD12 ' A' ' 17' ' ' ILE . 13.4 t70 -85.55 -32.89 21.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.473 0.654 . . . . 0.0 109.904 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.585 ' HD2' HG13 ' A' ' 17' ' ' ILE . 58.2 mtp180 -89.25 -41.92 11.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.728 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.27 -116.53 0.29 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -164.4 101.95 0.83 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.605 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.64 HG21 ' HB3' ' A' ' 36' ' ' CYS . 70.0 p -133.92 163.0 30.49 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.001 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -102.35 -39.22 7.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.61 150.86 23.15 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.291 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -141.31 137.21 32.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -126.39 139.28 53.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.998 0.428 . . . . 0.0 111.099 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.781 ' SG ' ' HA ' ' A' ' 11' ' ' SER . 56.0 m -79.83 107.05 12.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.51 173.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.5 tp -117.58 -45.25 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.05 -171.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -97.82 16.34 21.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.139 0.971 . . . . 0.0 109.873 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.65 -13.88 64.82 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 14.5 ptt180 -122.53 165.34 16.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.286 -0.957 . . . . 0.0 108.658 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 2.0 p -96.83 119.38 35.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.288 0.566 . . . . 0.0 111.715 -172.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.0 m -99.55 131.87 45.26 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.558 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.64 ' HB3' HG21 ' A' ' 24' ' ' THR . 29.5 m -98.5 135.78 39.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -113.91 90.63 19.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.105 0.479 . . . . 0.0 111.039 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 32.8 Cg_endo . . . . . 0 N--CA 1.444 -1.398 0 C-N-CA 124.395 3.397 . . . . 0.0 111.9 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.859 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 78.1 mt . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.635 0.255 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -122.65 122.57 39.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.079 0.466 . . . . 0.0 110.264 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 p -97.17 1.16 49.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.892 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.692 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 37.4 t30 52.98 71.71 0.47 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.966 0.888 . . . . 0.0 110.119 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.2 t -134.68 110.06 12.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.514 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 7' ' ' LYS . 23.8 mmmt -48.82 117.73 2.21 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.692 0.62 . . . . 0.0 110.232 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.1 p -83.0 145.84 29.1 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.108 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p -103.28 28.35 6.45 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.876 171.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.13 -113.54 0.94 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.782 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.1 p -164.38 -27.66 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.892 0.377 . . . . 0.0 110.385 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.432 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 10.7 p -60.59 -14.86 22.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.856 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 17' ' ' ILE . 4.7 tmtm? -69.12 -61.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.553 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -63.61 -48.72 76.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.45 -174.474 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.481 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 6.0 p -54.15 -33.51 25.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -86.36 -52.04 5.86 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.162 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.605 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 4.1 tp -72.03 -32.05 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -172.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 t -60.77 -24.19 65.58 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.977 0.417 . . . . 0.0 110.356 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.8 mt -69.72 -39.44 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.809 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.587 ' HB2' HD12 ' A' ' 17' ' ' ILE . 16.4 m-20 -77.41 -14.08 59.78 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.097 0.475 . . . . 0.0 110.65 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 49.0 mtm180 -98.65 -47.6 5.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.845 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -115.1 -109.11 0.36 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -161.85 15.57 0.09 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.067 0.461 . . . . 0.0 110.881 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 36' ' ' CYS . 6.4 t -104.54 139.84 38.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.994 0.426 . . . . 0.0 110.821 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.66 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -101.67 -2.65 29.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.643 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.9 97.87 0.84 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.994 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.553 ' HB1' ' HB2' ' A' ' 14' ' ' CYS . . . -131.88 131.35 42.68 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 29' ' ' CYS . 26.4 ttpt -133.36 148.93 51.87 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.116 -176.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 15.0 t -85.87 127.16 34.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 172.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.658 HG23 ' H ' ' A' ' 31' ' ' ASN . 4.3 tp -112.75 -71.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.729 -176.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.658 ' H ' HG23 ' A' ' 30' ' ' ILE . 21.6 t-20 -98.27 40.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.519 0.676 . . . . 0.0 109.922 -176.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.64 3.79 70.91 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.259 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.692 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 5.9 ptp180 -134.19 157.08 47.15 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 1.5 m -89.08 120.46 30.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.998 0.428 . . . . 0.0 111.499 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.0 m -123.29 139.91 53.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.726 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.859 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 32.8 m -99.07 132.29 44.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -119.93 83.76 30.89 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.136 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo . . . . . 0 C--O 1.246 0.92 0 C-N-CA 122.838 2.359 . . . . 0.0 111.711 177.491 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.871 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 87.5 mt . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.406 0.622 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -90.82 106.71 18.7 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 6' ' ' VAL . 24.8 p -75.37 -24.74 57.31 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.423 -173.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.8 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 66.2 t30 67.26 40.37 2.79 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 122.832 1.301 . . . . 0.0 107.664 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 5.1 t -124.04 126.83 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 112.999 -1.91 . . . . 0.0 109.747 -170.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -60.55 144.16 52.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.345 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.67 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 4.1 p -104.7 129.48 52.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.15 0.5 . . . . 0.0 111.905 -176.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 m -96.46 21.46 9.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.639 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.76 34.66 0.9 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.038 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.487 ' O ' HG12 ' A' ' 15' ' ' VAL . 68.7 m 71.46 -37.64 0.4 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.479 0.712 . . . . 0.0 112.9 175.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.568 ' HA ' HG12 ' A' ' 15' ' ' VAL . 22.0 t -62.4 -19.96 63.97 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.455 0.645 . . . . 0.0 109.909 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -57.22 -43.23 82.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.706 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -97.52 -49.24 4.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.283 -175.228 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 12' ' ' SER . 14.9 p -62.11 -8.95 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.367 0.603 . . . . 0.0 111.666 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -96.8 -51.49 4.26 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.997 -0.439 . . . . 0.0 110.703 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.633 HD12 ' HB3' ' A' ' 20' ' ' ASP . 1.7 tp -85.32 -32.85 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.1 t -62.85 -25.81 68.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.45 0.643 . . . . 0.0 109.704 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 24' ' ' THR . 1.7 mp -77.63 -33.4 19.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.404 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.633 ' HB3' HD12 ' A' ' 17' ' ' ILE . 8.5 t70 -76.17 -35.83 58.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.363 0.602 . . . . 0.0 109.64 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -75.35 -52.56 10.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.254 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -111.93 -113.57 0.33 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.113 0.483 . . . . 0.0 112.246 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -159.04 19.73 0.19 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.52 -170.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.658 ' O ' HG13 ' A' ' 19' ' ' ILE . 9.0 t -100.77 171.48 7.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.145 -174.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.5 -1.35 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.031 0.443 . . . . 0.0 110.347 173.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.76 67.62 0.36 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.49 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 14' ' ' CYS . . . -104.93 132.4 51.22 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -139.65 150.75 45.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.024 0.44 . . . . 0.0 111.506 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 38.9 t -80.79 106.79 13.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.48 HG21 ' OH ' ' A' ' 37' ' ' TYR . 3.7 tp -129.84 -46.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -167.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -108.17 33.64 4.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.824 0.345 . . . . 0.0 110.854 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.49 -5.98 62.5 Favored Glycine 0 CA--C 1.507 -0.411 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -172.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.8 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 19.4 ptt-85 -140.65 176.88 8.43 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.578 -0.811 . . . . 0.0 109.094 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.6 m -95.14 126.35 40.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.404 0.621 . . . . 0.0 112.278 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.0 m -119.95 132.16 55.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.222 174.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.871 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 38.7 m -100.04 125.59 46.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.299 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.48 ' OH ' HG21 ' A' ' 30' ' ' ILE . 32.9 m-85 -109.64 91.07 9.75 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.55 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 3.0 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.329 2.686 . . . . 0.0 111.798 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.794 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 1.6 mp . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 121.039 0.447 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -113.06 100.41 8.59 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 170.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 6' ' ' VAL . 67.9 p -69.41 -23.06 63.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.455 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 59.83 32.86 21.52 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 122.094 0.949 . . . . 0.0 109.524 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 4' ' ' THR . 88.3 t -123.78 120.06 58.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.142 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 41.0 mtmt -49.42 139.97 11.09 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.214 0.946 . . . . 0.0 112.224 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 p -94.39 162.28 13.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.1 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.4 m -111.14 30.04 7.25 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.47 158.29 14.86 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.777 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.4 p -63.82 -21.9 66.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.231 0.515 . . . . 0.0 111.447 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.8 m -60.13 -28.75 68.14 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.451 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -72.69 -51.09 20.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.129 0.49 . . . . 0.0 109.99 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -63.48 -45.48 90.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.212 -175.037 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 12.3 p -62.78 -15.72 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.163 0.506 . . . . 0.0 111.387 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -102.88 -50.8 3.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.961 0.41 . . . . 0.0 110.423 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.521 HD12 ' HB3' ' A' ' 20' ' ' ASP . 3.0 tp -77.95 -22.5 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.74 -17.54 64.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.101 0.477 . . . . 0.0 110.102 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.29 -27.4 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.307 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.521 ' HB3' HD12 ' A' ' 17' ' ' ILE . 24.1 t70 -86.26 -44.84 11.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.246 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -69.32 -49.83 52.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.941 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.64 -111.71 0.33 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.933 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -161.59 12.92 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.447 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.557 HG21 ' HG3' ' A' ' 38' ' ' PRO . 22.9 p -119.95 129.52 54.35 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -165.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.667 ' HD2' ' N ' ' A' ' 26' ' ' GLY . 1.9 ppt_? -84.97 -11.14 56.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.082 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.667 ' N ' ' HD2' ' A' ' 25' ' ' ARG . . . -95.35 100.53 2.56 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.639 -175.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -140.96 142.42 34.34 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.903 0.382 . . . . 0.0 111.025 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -145.48 141.75 28.62 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.9 t -84.88 112.66 20.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.583 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.4 tp -99.07 -63.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.583 ' H ' HG23 ' A' ' 30' ' ' ILE . 23.9 p-10 -105.38 17.1 24.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.419 0.628 . . . . 0.0 110.204 -174.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 104.57 -5.75 44.39 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.598 -176.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 17.5 mmt-85 -108.38 172.45 6.83 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 47.9 m -91.2 110.64 21.93 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.903 175.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 84.9 m -117.86 131.36 56.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.223 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.794 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 28.4 m -106.1 134.74 48.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.597 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -118.83 87.88 34.23 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.729 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HG3' HG21 ' A' ' 24' ' ' THR . 8.4 Cg_exo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.723 2.949 . . . . 0.0 112.549 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.823 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 47.5 mm . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 121.027 0.442 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -98.83 109.66 22.38 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.7 p -74.47 -13.68 60.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.861 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 60.0 39.79 19.54 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 109.969 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 69.3 t -115.86 104.53 16.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.237 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 48.1 mtpt -52.76 121.07 6.51 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.969 176.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.5 p -139.67 148.88 43.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.759 -176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 p -94.42 -51.28 4.84 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.15 123.37 7.91 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.761 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.831 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 34.8 m -62.18 -24.21 67.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 111.612 -177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.499 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 32.8 t -66.19 -30.63 71.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.077 -168.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -69.16 -15.83 63.5 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.129 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.445 ' HA ' HG22 ' A' ' 17' ' ' ILE . 72.7 m -102.93 -39.94 6.73 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.822 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 1.4 p -58.21 -35.69 54.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.427 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -72.62 -40.59 66.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.774 0.321 . . . . 0.0 111.355 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 14' ' ' CYS . 4.5 tp -86.39 -32.71 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.0 t -56.61 -26.91 57.01 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.035 0.445 . . . . 0.0 110.399 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 15' ' ' VAL . 78.1 mt -60.28 -41.0 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.408 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -85.1 -23.04 28.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.424 0.63 . . . . 0.0 110.481 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.96 -55.45 5.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.949 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.54 -108.07 0.33 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.505 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -161.21 18.18 0.11 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.975 0.417 . . . . 0.0 110.748 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.53 HG21 ' HB3' ' A' ' 36' ' ' CYS . 2.9 t -120.0 162.99 18.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 -173.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.699 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -126.17 2.49 7.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.309 -173.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.05 71.37 0.32 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.76 -174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' A' ' 15' ' ' VAL . . . -99.05 144.97 27.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.911 0.386 . . . . 0.0 110.188 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -147.78 141.95 26.11 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.926 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.831 ' SG ' ' HA ' ' A' ' 11' ' ' SER . 70.2 m -79.43 100.62 7.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.726 HG23 ' H ' ' A' ' 31' ' ' ASN . 6.1 tp -98.46 -66.09 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.757 -170.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.726 ' H ' HG23 ' A' ' 30' ' ' ILE . 92.4 m-20 -96.64 34.98 1.57 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.28 4.66 89.46 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.402 -174.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.5 mmt85 -128.75 157.96 39.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 m -77.18 112.76 14.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.531 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 61.4 m -116.98 128.06 54.81 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.823 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 46.3 m -99.13 128.02 45.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.346 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -110.95 92.52 15.07 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.183 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 10.2 Cg_exo . . . . . 0 C--O 1.25 1.092 0 C-N-CA 123.227 2.618 . . . . 0.0 111.742 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.741 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 34.0 mm . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.843 0.354 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -90.14 100.34 13.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -72.89 -11.65 60.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.068 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.78 46.1 14.64 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.909 0.861 . . . . 0.0 109.643 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 74.2 t -119.83 103.69 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.416 -173.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HG3' ' H ' ' A' ' 7' ' ' LYS . 27.0 mtmm -56.07 120.98 8.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.602 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.9 p -133.53 160.72 36.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.344 0.592 . . . . 0.0 112.17 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.8 m -121.8 -0.2 9.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.446 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.75 143.41 10.75 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.248 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 15' ' ' VAL . 10.7 m -90.56 -26.76 19.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.627 0.251 . . . . 0.0 111.257 -177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 t -60.62 -42.54 97.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.061 -170.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -63.79 -29.18 70.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.772 0.32 . . . . 0.0 110.987 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.55 ' HA ' HG22 ' A' ' 17' ' ' ILE . 98.8 m -85.08 -46.01 11.56 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.673 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 2.6 p -59.71 -33.57 52.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.623 0.249 . . . . 0.0 111.454 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -79.14 -36.49 40.44 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.057 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 20' ' ' ASP . 4.0 tp -85.48 -23.11 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.147 0.499 . . . . 0.0 111.405 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.704 ' SG ' HG23 ' A' ' 24' ' ' THR . 41.8 t -63.3 -20.52 65.55 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.14 0.495 . . . . 0.0 110.106 176.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.8 mt -75.41 -32.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.463 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.643 ' HB3' HD12 ' A' ' 17' ' ' ILE . 12.4 t70 -83.89 -43.9 14.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.339 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.52 -38.74 81.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.946 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -123.07 -109.38 0.33 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -162.51 4.62 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.053 0.454 . . . . 0.0 111.152 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.704 HG23 ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -105.76 154.52 20.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.17 0.51 . . . . 0.0 111.415 -170.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -118.29 16.42 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.808 -168.401 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.2 55.43 0.74 Allowed Glycine 0 C--O 1.224 -0.503 0 C-N-CA 119.684 -1.246 . . . . 0.0 113.554 -173.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.732 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -97.89 130.51 44.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.278 0.539 . . . . 0.0 111.044 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 84.8 tttt -130.47 140.72 50.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.413 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.0 t -81.69 92.29 6.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.473 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.2 tp -116.96 -58.37 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -168.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.473 ' H ' HG23 ' A' ' 30' ' ' ILE . 4.3 t30 -95.18 40.74 1.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.533 0.682 . . . . 0.0 109.516 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.98 -0.52 72.36 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.142 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 7.3 ptp180 -141.13 165.3 27.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 63.3 m -83.3 106.49 15.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.8 m -100.49 126.72 46.94 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.741 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -99.76 122.65 43.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.079 -176.492 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -106.31 96.15 12.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.569 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 8.2 Cg_exo . . . . . 0 C--O 1.25 1.079 0 C-N-CA 123.727 2.951 . . . . 0.0 112.14 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.791 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 36.6 mt . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 121.253 0.549 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -101.83 122.78 44.63 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.435 HG22 ' HE2' ' A' ' 22' ' ' TYR . 17.9 p -78.79 -5.04 52.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.538 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.5 t30 58.71 39.08 24.74 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 122.602 1.192 . . . . 0.0 109.016 -173.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.8 112.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.036 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -63.07 132.63 52.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 19.6 p -101.53 130.26 47.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.255 0.55 . . . . 0.0 112.114 -169.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -106.6 15.3 25.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.842 0.829 . . . . 0.0 108.783 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.08 137.74 2.28 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.537 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 15' ' ' VAL . 19.4 m -70.06 -26.65 64.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.177 0.489 . . . . 0.0 111.641 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -66.42 -43.07 86.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -170.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -33.92 75.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.282 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 10.2 m -67.13 -58.15 5.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.617 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 19' ' ' ILE . 2.4 p -57.55 -35.35 49.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.18 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.41 -52.92 55.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.226 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 20' ' ' ASP . 2.5 tp -81.43 -24.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.129 0.49 . . . . 0.0 111.528 -173.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 20.1 t -63.86 -24.48 67.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.37 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 15' ' ' VAL . 64.7 mt -74.96 -39.95 45.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.692 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.485 ' HB3' HD12 ' A' ' 17' ' ' ILE . 14.4 t70 -76.26 -39.43 54.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.269 0.557 . . . . 0.0 109.792 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 21' ' ' ARG . 33.7 mtt180 -67.46 -56.41 9.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.021 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.435 ' HE2' HG22 ' A' ' 4' ' ' THR . 59.1 m-85 -109.37 -101.87 0.38 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 -172.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -160.39 -15.08 0.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.218 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.457 HG21 ' HB3' ' A' ' 36' ' ' CYS . 4.7 t -101.47 163.92 12.02 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.329 -165.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.719 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -137.29 13.03 3.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.535 -167.158 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.67 79.37 0.37 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.58 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.17 141.16 47.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.024 0.44 . . . . 0.0 111.029 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -127.54 136.35 51.59 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.504 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 43.9 t -79.67 103.3 9.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.546 HG23 ' H ' ' A' ' 31' ' ' ASN . 4.9 tp -127.97 -64.34 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -169.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.546 ' H ' HG23 ' A' ' 30' ' ' ILE . 95.8 m-20 -95.77 33.71 1.62 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.047 0.451 . . . . 0.0 110.899 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.71 -12.86 67.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.716 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -133.48 169.67 16.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.874 0.369 . . . . 0.0 110.579 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 18.8 m -76.31 123.15 25.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.571 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -117.46 120.66 38.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.196 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.791 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 59.9 m -98.99 125.86 44.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.415 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -105.36 92.68 5.97 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.323 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 15.4 Cg_exo . . . . . 0 C--O 1.247 0.947 0 C-N-CA 123.45 2.767 . . . . 0.0 112.145 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 77.3 mt . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.75 0.31 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -108.48 129.23 55.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 6' ' ' VAL . 13.8 p -85.96 -0.03 54.45 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.456 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 62.8 t30 55.29 42.64 30.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 122.413 1.101 . . . . 0.0 109.265 -174.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 4' ' ' THR . 54.2 t -129.89 113.26 26.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.167 -1.378 . . . . 0.0 110.097 -174.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -51.62 138.36 22.99 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.754 0.659 . . . . 0.0 110.146 176.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 p -79.0 134.31 36.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.465 0.65 . . . . 0.0 111.598 -168.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 t -96.76 43.21 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.843 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.63 21.79 7.36 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.367 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.401 ' O ' HG23 ' A' ' 15' ' ' VAL . 91.5 p 65.46 -51.41 0.37 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.923 1.289 . . . . 0.0 113.267 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 t -63.22 -36.4 83.52 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.552 0.341 . . . . 0.0 111.877 -173.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -50.84 -45.58 59.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.153 0.501 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 1.5 m -67.49 -44.06 79.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.305 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.624 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 16.2 t -55.82 -40.14 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -74.28 -55.53 5.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.612 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 20' ' ' ASP . 2.8 tp -77.36 -28.0 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -169.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.436 ' SG ' HG21 ' A' ' 24' ' ' THR . 7.8 t -62.49 -26.41 68.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.974 0.416 . . . . 0.0 110.024 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 24' ' ' THR . 59.5 mt -71.74 -44.91 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.49 ' HB3' HD12 ' A' ' 17' ' ' ILE . 23.3 t70 -68.79 -36.06 77.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.232 0.539 . . . . 0.0 110.425 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.73 -45.32 25.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.101 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -121.81 -114.09 0.32 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.422 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -161.73 92.06 0.85 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.287 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.655 HG22 ' HG3' ' A' ' 38' ' ' PRO . 72.8 p -135.68 153.61 51.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.297 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -117.46 6.25 12.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.059 0.457 . . . . 0.0 109.811 174.177 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.87 127.96 1.36 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.479 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' A' ' 15' ' ' VAL . . . -128.75 159.35 35.96 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -149.54 155.76 40.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.196 0.522 . . . . 0.0 111.326 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.1 t -96.61 100.23 11.81 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 tp -99.52 -50.9 10.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.729 -170.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -115.65 19.7 15.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.781 0.8 . . . . 0.0 109.709 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.25 -7.37 32.56 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.709 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 10.7 ptt180 -131.31 170.94 13.94 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.585 -0.362 . . . . 0.0 110.888 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 32.7 m -75.73 123.25 25.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.538 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.5 m -126.16 122.2 35.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.486 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.682 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 34.2 m -98.07 136.46 38.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.303 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -117.48 84.23 18.3 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.686 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.655 ' HG3' HG22 ' A' ' 24' ' ' THR . 11.4 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.268 2.646 . . . . 0.0 111.655 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.778 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 92.6 mt . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.634 0.254 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -98.9 131.67 44.81 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -79.7 -22.17 43.72 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.61 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 4.8 t-20 67.58 38.7 3.0 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.092 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.14 128.21 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.994 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 43.4 mtmt -64.99 145.17 56.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.6 p -114.57 152.99 30.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 p -78.69 -39.48 36.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.623 0.725 . . . . 0.0 109.681 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.73 169.08 31.17 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.498 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.583 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 15.8 p -57.82 -28.43 64.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.937 0.399 . . . . 0.0 111.533 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.578 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 47.9 t -73.78 -8.33 55.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.229 -174.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -65.86 -53.93 33.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.918 0.389 . . . . 0.0 110.937 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 1.2 m -77.17 -40.93 43.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.578 ' CG1' ' HA ' ' A' ' 12' ' ' SER . 6.0 p -57.71 -26.9 28.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -172.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -87.61 -40.89 13.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.288 178.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.654 HD12 ' HB3' ' A' ' 20' ' ' ASP . 4.5 tp -85.14 -27.17 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.231 0.539 . . . . 0.0 111.738 -172.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.7 t -60.75 -21.43 62.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.358 0.599 . . . . 0.0 109.826 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.2 mt -79.53 -29.96 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.075 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.654 ' HB3' HD12 ' A' ' 17' ' ' ILE . 30.3 t70 -85.32 -29.49 24.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.681 0.753 . . . . 0.0 109.945 -174.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 55.1 mtp180 -92.03 -43.86 9.18 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.226 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -110.05 -111.5 0.32 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.142 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -162.13 6.41 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 t -115.69 142.52 46.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.356 0.598 . . . . 0.0 111.797 -172.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -98.29 7.48 46.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.284 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.59 103.25 1.62 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.11 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -142.48 140.04 31.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.892 0.377 . . . . 0.0 110.762 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -138.01 142.7 40.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.204 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 82.1 m -80.2 133.42 36.02 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.437 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.2 tp -121.77 -55.79 3.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.947 -171.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.437 ' H ' HG23 ' A' ' 30' ' ' ILE . 15.8 t-20 -129.95 61.93 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.74 -26.07 2.05 Favored Glycine 0 CA--C 1.517 0.202 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.413 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.61 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 37.8 ttp180 -109.25 149.01 30.05 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 8.4 p -95.98 141.86 28.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 0.0 111.237 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.6 m -131.18 145.05 51.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.065 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.778 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 39.8 m -97.75 123.81 41.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.905 0.383 . . . . 0.0 110.306 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -116.6 85.87 17.55 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.161 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 17.9 Cg_exo . . . . . 0 C--O 1.248 1.014 0 C-N-CA 122.995 2.463 . . . . 0.0 111.521 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.862 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 77.9 mt -83.88 101.81 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.03 0.443 . . . . 0.0 110.94 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -116.37 101.54 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.712 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 p -90.11 3.16 54.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.36 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t30 57.82 51.75 8.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 122.193 0.997 . . . . 0.0 109.693 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 85.9 t -124.57 118.6 53.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.705 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.17 148.29 48.46 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.506 0.503 . . . . 0.0 109.725 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.4 p -86.74 111.42 20.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.492 0.663 . . . . 0.0 111.536 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -86.43 32.91 0.63 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.18 128.83 4.94 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.53 -170.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 m -61.07 -19.02 60.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.071 0.436 . . . . 0.0 110.83 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.472 ' HA ' HG12 ' A' ' 15' ' ' VAL . 13.3 m -81.7 -5.84 58.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.763 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 17' ' ' ILE . 3.6 ttmp? -82.97 -51.19 7.8 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -62.39 -46.96 86.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.986 -178.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 12' ' ' SER . 7.1 p -57.67 -27.99 31.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.675 0.274 . . . . 0.0 111.524 -175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -88.97 -43.84 10.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.731 0.301 . . . . 0.0 111.174 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 14' ' ' CYS . 3.1 tp -82.29 -29.69 9.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.0 0.428 . . . . 0.0 112.031 -173.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.635 ' HA ' ' HD2' ' A' ' 21' ' ' ARG . 7.7 t -65.47 -20.24 66.27 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.061 0.458 . . . . 0.0 110.056 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 25' ' ' ARG . 66.5 mt -64.74 -39.46 85.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.312 173.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.63 -23.53 49.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.063 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.635 ' HD2' ' HA ' ' A' ' 18' ' ' CYS . 99.7 mtt180 -67.41 -67.43 0.46 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.267 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.11 -94.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.002 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -160.08 18.4 0.15 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 -174.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' A' ' 38' ' ' PRO . 8.4 t -103.73 161.1 14.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.05 0.452 . . . . 0.0 110.855 -173.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HA ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -124.39 10.15 8.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.465 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.57 119.29 1.46 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.04 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -141.16 144.56 34.89 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -141.64 145.59 35.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.994 0.426 . . . . 0.0 110.918 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 29.3 t -86.18 110.24 19.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -116.85 -46.57 3.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.474 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.527 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 27.3 p-10 -108.25 20.04 19.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.236 0.541 . . . . 0.0 110.603 -176.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.86 -6.07 54.15 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.057 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.527 ' HG2' ' OD1' ' A' ' 31' ' ' ASN . 11.4 ptp180 -130.95 167.99 18.08 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 14.9 m -89.98 113.08 24.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.8 m -112.55 135.67 53.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.573 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.862 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 17.7 m -99.7 130.78 45.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.798 0.332 . . . . 0.0 110.284 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -120.78 86.22 40.62 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.612 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 2.9 Cg_exo . . . . . 0 C--O 1.251 1.17 0 C-N-CA 123.149 2.566 . . . . 0.0 111.969 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.269 . . . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.3 mt -125.07 124.41 67.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.141 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -103.46 125.49 50.07 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.7 p -75.63 -22.16 57.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.344 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 65.67 36.86 6.12 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.504 1.145 . . . . 0.0 108.65 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 3.2 t -135.8 114.47 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 112.929 -1.942 . . . . 0.0 110.222 -172.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 143.47 56.57 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.041 0.448 . . . . 0.0 110.319 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 p -122.22 160.6 24.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.644 -172.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 p -85.93 -48.65 8.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.276 172.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.54 162.55 25.46 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.781 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 20.5 m -62.13 -18.78 61.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.2 0.5 . . . . 0.0 111.346 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.419 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 15.5 p -64.68 -15.35 61.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.193 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -62.18 -55.2 31.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.921 0.391 . . . . 0.0 111.441 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.543 ' HA ' HG22 ' A' ' 17' ' ' ILE . 9.6 m -82.51 -41.67 19.41 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.433 ' N ' ' HB3' ' A' ' 27' ' ' ALA . 2.5 p -51.22 -33.64 13.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -172.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -46.43 10.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.753 0.311 . . . . 0.0 110.735 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 20' ' ' ASP . 3.5 tp -77.43 -29.55 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 111.937 -171.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -64.33 -15.91 61.21 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.776 178.015 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.9 mt -85.65 -25.53 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.153 0.502 . . . . 0.0 110.216 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.679 ' HB3' HD12 ' A' ' 17' ' ' ILE . 13.4 t70 -85.55 -32.89 21.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.473 0.654 . . . . 0.0 109.904 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.585 ' HD2' HG13 ' A' ' 17' ' ' ILE . 58.2 mtp180 -89.25 -41.92 11.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.728 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.27 -116.53 0.29 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -164.4 101.95 0.83 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.605 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.64 HG21 ' HB3' ' A' ' 36' ' ' CYS . 70.0 p -133.92 163.0 30.49 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.001 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -102.35 -39.22 7.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.61 150.86 23.15 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.291 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -141.31 137.21 32.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -126.39 139.28 53.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.998 0.428 . . . . 0.0 111.099 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.781 ' SG ' ' HA ' ' A' ' 11' ' ' SER . 56.0 m -79.83 107.05 12.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.51 173.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.5 tp -117.58 -45.25 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.05 -171.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -97.82 16.34 21.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.139 0.971 . . . . 0.0 109.873 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.65 -13.88 64.82 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 14.5 ptt180 -122.53 165.34 16.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.286 -0.957 . . . . 0.0 108.658 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 2.0 p -96.83 119.38 35.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.288 0.566 . . . . 0.0 111.715 -172.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.0 m -99.55 131.87 45.26 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.558 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.64 ' HB3' HG21 ' A' ' 24' ' ' THR . 29.5 m -98.5 135.78 39.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -113.91 90.63 19.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.105 0.479 . . . . 0.0 111.039 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 32.8 Cg_endo . . . . . 0 N--CA 1.444 -1.398 0 C-N-CA 124.395 3.397 . . . . 0.0 111.9 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.292 . . . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.859 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 78.1 mt -91.38 102.43 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.46 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -122.65 122.57 39.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.079 0.466 . . . . 0.0 110.264 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 p -97.17 1.16 49.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.892 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.692 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 37.4 t30 52.98 71.71 0.47 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.966 0.888 . . . . 0.0 110.119 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.2 t -134.68 110.06 12.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.514 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 7' ' ' LYS . 23.8 mmmt -48.82 117.73 2.21 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.692 0.62 . . . . 0.0 110.232 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.1 p -83.0 145.84 29.1 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.108 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p -103.28 28.35 6.45 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.876 171.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.13 -113.54 0.94 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.782 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.1 p -164.38 -27.66 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.892 0.377 . . . . 0.0 110.385 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.432 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 10.7 p -60.59 -14.86 22.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.856 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 17' ' ' ILE . 4.7 tmtm? -69.12 -61.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.553 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -63.61 -48.72 76.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.45 -174.474 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.481 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 6.0 p -54.15 -33.51 25.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -86.36 -52.04 5.86 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.162 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.605 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 4.1 tp -72.03 -32.05 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -172.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 t -60.77 -24.19 65.58 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.977 0.417 . . . . 0.0 110.356 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.8 mt -69.72 -39.44 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.809 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.587 ' HB2' HD12 ' A' ' 17' ' ' ILE . 16.4 m-20 -77.41 -14.08 59.78 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.097 0.475 . . . . 0.0 110.65 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 49.0 mtm180 -98.65 -47.6 5.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.845 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -115.1 -109.11 0.36 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -161.85 15.57 0.09 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.067 0.461 . . . . 0.0 110.881 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 36' ' ' CYS . 6.4 t -104.54 139.84 38.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.994 0.426 . . . . 0.0 110.821 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.66 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -101.67 -2.65 29.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.643 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.9 97.87 0.84 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.994 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.553 ' HB1' ' HB2' ' A' ' 14' ' ' CYS . . . -131.88 131.35 42.68 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 29' ' ' CYS . 26.4 ttpt -133.36 148.93 51.87 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.116 -176.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 15.0 t -85.87 127.16 34.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 172.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.658 HG23 ' H ' ' A' ' 31' ' ' ASN . 4.3 tp -112.75 -71.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.729 -176.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.658 ' H ' HG23 ' A' ' 30' ' ' ILE . 21.6 t-20 -98.27 40.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.519 0.676 . . . . 0.0 109.922 -176.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.64 3.79 70.91 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.259 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.692 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 5.9 ptp180 -134.19 157.08 47.15 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 1.5 m -89.08 120.46 30.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.998 0.428 . . . . 0.0 111.499 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.0 m -123.29 139.91 53.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.726 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.859 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 32.8 m -99.07 132.29 44.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -119.93 83.76 30.89 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.136 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo . . . . . 0 C--O 1.246 0.92 0 C-N-CA 122.838 2.359 . . . . 0.0 111.711 177.491 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.277 . . . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.871 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 87.5 mt -87.28 84.84 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.406 0.622 . . . . 0.0 110.116 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -90.82 106.71 18.7 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 6' ' ' VAL . 24.8 p -75.37 -24.74 57.31 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.423 -173.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.8 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 66.2 t30 67.26 40.37 2.79 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 122.832 1.301 . . . . 0.0 107.664 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 5.1 t -124.04 126.83 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 112.999 -1.91 . . . . 0.0 109.747 -170.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -60.55 144.16 52.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.345 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.67 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 4.1 p -104.7 129.48 52.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.15 0.5 . . . . 0.0 111.905 -176.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 m -96.46 21.46 9.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.639 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.76 34.66 0.9 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.038 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.487 ' O ' HG12 ' A' ' 15' ' ' VAL . 68.7 m 71.46 -37.64 0.4 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.479 0.712 . . . . 0.0 112.9 175.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.568 ' HA ' HG12 ' A' ' 15' ' ' VAL . 22.0 t -62.4 -19.96 63.97 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.455 0.645 . . . . 0.0 109.909 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -57.22 -43.23 82.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.706 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.606 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -97.52 -49.24 4.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.283 -175.228 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 12' ' ' SER . 14.9 p -62.11 -8.95 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.367 0.603 . . . . 0.0 111.666 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -96.8 -51.49 4.26 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.997 -0.439 . . . . 0.0 110.703 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.633 HD12 ' HB3' ' A' ' 20' ' ' ASP . 1.7 tp -85.32 -32.85 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.1 t -62.85 -25.81 68.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.45 0.643 . . . . 0.0 109.704 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 24' ' ' THR . 1.7 mp -77.63 -33.4 19.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.404 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.633 ' HB3' HD12 ' A' ' 17' ' ' ILE . 8.5 t70 -76.17 -35.83 58.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.363 0.602 . . . . 0.0 109.64 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -75.35 -52.56 10.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.254 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -111.93 -113.57 0.33 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.113 0.483 . . . . 0.0 112.246 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -159.04 19.73 0.19 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.52 -170.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.658 ' O ' HG13 ' A' ' 19' ' ' ILE . 9.0 t -100.77 171.48 7.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.145 -174.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.5 -1.35 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.031 0.443 . . . . 0.0 110.347 173.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.76 67.62 0.36 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.49 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 14' ' ' CYS . . . -104.93 132.4 51.22 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -139.65 150.75 45.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.024 0.44 . . . . 0.0 111.506 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 38.9 t -80.79 106.79 13.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.48 HG21 ' OH ' ' A' ' 37' ' ' TYR . 3.7 tp -129.84 -46.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -167.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -108.17 33.64 4.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.824 0.345 . . . . 0.0 110.854 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.49 -5.98 62.5 Favored Glycine 0 CA--C 1.507 -0.411 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -172.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.8 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 19.4 ptt-85 -140.65 176.88 8.43 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.578 -0.811 . . . . 0.0 109.094 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.6 m -95.14 126.35 40.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.404 0.621 . . . . 0.0 112.278 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.0 m -119.95 132.16 55.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.222 174.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.871 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 38.7 m -100.04 125.59 46.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.299 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.48 ' OH ' HG21 ' A' ' 30' ' ' ILE . 32.9 m-85 -109.64 91.07 9.75 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.55 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 3.0 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.329 2.686 . . . . 0.0 111.798 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.278 . . . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.794 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 1.6 mp -68.19 110.09 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.981 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -113.06 100.41 8.59 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 170.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 6' ' ' VAL . 67.9 p -69.41 -23.06 63.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.455 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 59.83 32.86 21.52 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 122.094 0.949 . . . . 0.0 109.524 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 4' ' ' THR . 88.3 t -123.78 120.06 58.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.142 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 41.0 mtmt -49.42 139.97 11.09 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.214 0.946 . . . . 0.0 112.224 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 p -94.39 162.28 13.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.1 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.4 m -111.14 30.04 7.25 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.47 158.29 14.86 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.777 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.4 p -63.82 -21.9 66.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.231 0.515 . . . . 0.0 111.447 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.8 m -60.13 -28.75 68.14 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.451 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -72.69 -51.09 20.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.129 0.49 . . . . 0.0 109.99 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -63.48 -45.48 90.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.212 -175.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 12.3 p -62.78 -15.72 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.163 0.506 . . . . 0.0 111.387 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -102.88 -50.8 3.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.961 0.41 . . . . 0.0 110.423 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.521 HD12 ' HB3' ' A' ' 20' ' ' ASP . 3.0 tp -77.95 -22.5 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.74 -17.54 64.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.101 0.477 . . . . 0.0 110.102 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.29 -27.4 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.307 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.521 ' HB3' HD12 ' A' ' 17' ' ' ILE . 24.1 t70 -86.26 -44.84 11.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.246 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -69.32 -49.83 52.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.941 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.64 -111.71 0.33 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.933 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -161.59 12.92 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.447 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.557 HG21 ' HG3' ' A' ' 38' ' ' PRO . 22.9 p -119.95 129.52 54.35 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -165.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.667 ' HD2' ' N ' ' A' ' 26' ' ' GLY . 1.9 ppt_? -84.97 -11.14 56.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.082 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.667 ' N ' ' HD2' ' A' ' 25' ' ' ARG . . . -95.35 100.53 2.56 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.639 -175.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -140.96 142.42 34.34 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.903 0.382 . . . . 0.0 111.025 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -145.48 141.75 28.62 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.9 t -84.88 112.66 20.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.583 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.4 tp -99.07 -63.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.583 ' H ' HG23 ' A' ' 30' ' ' ILE . 23.9 p-10 -105.38 17.1 24.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.419 0.628 . . . . 0.0 110.204 -174.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 104.57 -5.75 44.39 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.598 -176.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 17.5 mmt-85 -108.38 172.45 6.83 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 47.9 m -91.2 110.64 21.93 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.903 175.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 84.9 m -117.86 131.36 56.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.223 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.794 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 28.4 m -106.1 134.74 48.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.597 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -118.83 87.88 34.23 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.729 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HG3' HG21 ' A' ' 24' ' ' THR . 8.4 Cg_exo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.723 2.949 . . . . 0.0 112.549 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.281 . . . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.823 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 47.5 mm -82.65 86.98 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.027 0.442 . . . . 0.0 110.27 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -98.83 109.66 22.38 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.7 p -74.47 -13.68 60.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.861 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 60.0 39.79 19.54 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 109.969 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 69.3 t -115.86 104.53 16.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.237 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 48.1 mtpt -52.76 121.07 6.51 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.969 176.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.5 p -139.67 148.88 43.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.759 -176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 p -94.42 -51.28 4.84 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.15 123.37 7.91 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.761 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.831 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 34.8 m -62.18 -24.21 67.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 111.612 -177.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.499 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 32.8 t -66.19 -30.63 71.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.077 -168.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -69.16 -15.83 63.5 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.129 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.445 ' HA ' HG22 ' A' ' 17' ' ' ILE . 72.7 m -102.93 -39.94 6.73 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.822 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 1.4 p -58.21 -35.69 54.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.427 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -72.62 -40.59 66.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.774 0.321 . . . . 0.0 111.355 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 14' ' ' CYS . 4.5 tp -86.39 -32.71 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.0 t -56.61 -26.91 57.01 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.035 0.445 . . . . 0.0 110.399 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 15' ' ' VAL . 78.1 mt -60.28 -41.0 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.408 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -85.1 -23.04 28.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.424 0.63 . . . . 0.0 110.481 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.96 -55.45 5.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.949 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.54 -108.07 0.33 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.505 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -161.21 18.18 0.11 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.975 0.417 . . . . 0.0 110.748 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.53 HG21 ' HB3' ' A' ' 36' ' ' CYS . 2.9 t -120.0 162.99 18.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 -173.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.699 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -126.17 2.49 7.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.309 -173.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.05 71.37 0.32 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.76 -174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' A' ' 15' ' ' VAL . . . -99.05 144.97 27.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.911 0.386 . . . . 0.0 110.188 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -147.78 141.95 26.11 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.926 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.831 ' SG ' ' HA ' ' A' ' 11' ' ' SER . 70.2 m -79.43 100.62 7.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.726 HG23 ' H ' ' A' ' 31' ' ' ASN . 6.1 tp -98.46 -66.09 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.757 -170.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.726 ' H ' HG23 ' A' ' 30' ' ' ILE . 92.4 m-20 -96.64 34.98 1.57 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.28 4.66 89.46 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.402 -174.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.5 mmt85 -128.75 157.96 39.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 m -77.18 112.76 14.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.531 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 61.4 m -116.98 128.06 54.81 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.823 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 46.3 m -99.13 128.02 45.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.346 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -110.95 92.52 15.07 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.183 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 10.2 Cg_exo . . . . . 0 C--O 1.25 1.092 0 C-N-CA 123.227 2.618 . . . . 0.0 111.742 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.278 . . . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.741 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 34.0 mm -78.17 100.13 3.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.23 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -90.14 100.34 13.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -72.89 -11.65 60.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.068 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.78 46.1 14.64 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.909 0.861 . . . . 0.0 109.643 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 74.2 t -119.83 103.69 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.416 -173.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HG3' ' H ' ' A' ' 7' ' ' LYS . 27.0 mtmm -56.07 120.98 8.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.602 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.9 p -133.53 160.72 36.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.344 0.592 . . . . 0.0 112.17 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.8 m -121.8 -0.2 9.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.446 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.75 143.41 10.75 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.248 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 15' ' ' VAL . 10.7 m -90.56 -26.76 19.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.627 0.251 . . . . 0.0 111.257 -177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 t -60.62 -42.54 97.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.061 -170.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -63.79 -29.18 70.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.772 0.32 . . . . 0.0 110.987 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.55 ' HA ' HG22 ' A' ' 17' ' ' ILE . 98.8 m -85.08 -46.01 11.56 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.673 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 2.6 p -59.71 -33.57 52.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.623 0.249 . . . . 0.0 111.454 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -79.14 -36.49 40.44 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.057 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 20' ' ' ASP . 4.0 tp -85.48 -23.11 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.147 0.499 . . . . 0.0 111.405 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.704 ' SG ' HG23 ' A' ' 24' ' ' THR . 41.8 t -63.3 -20.52 65.55 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.14 0.495 . . . . 0.0 110.106 176.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.8 mt -75.41 -32.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.463 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.643 ' HB3' HD12 ' A' ' 17' ' ' ILE . 12.4 t70 -83.89 -43.9 14.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.339 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.52 -38.74 81.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.946 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -123.07 -109.38 0.33 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -162.51 4.62 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.053 0.454 . . . . 0.0 111.152 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.704 HG23 ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -105.76 154.52 20.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.17 0.51 . . . . 0.0 111.415 -170.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -118.29 16.42 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.808 -168.401 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.2 55.43 0.74 Allowed Glycine 0 C--O 1.224 -0.503 0 C-N-CA 119.684 -1.246 . . . . 0.0 113.554 -173.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.732 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -97.89 130.51 44.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.278 0.539 . . . . 0.0 111.044 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 84.8 tttt -130.47 140.72 50.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.413 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.0 t -81.69 92.29 6.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.473 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.2 tp -116.96 -58.37 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -168.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.473 ' H ' HG23 ' A' ' 30' ' ' ILE . 4.3 t30 -95.18 40.74 1.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.533 0.682 . . . . 0.0 109.516 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.98 -0.52 72.36 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.142 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 7.3 ptp180 -141.13 165.3 27.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 63.3 m -83.3 106.49 15.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.8 m -100.49 126.72 46.94 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.741 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -99.76 122.65 43.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.079 -176.492 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -106.31 96.15 12.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.569 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 8.2 Cg_exo . . . . . 0 C--O 1.25 1.079 0 C-N-CA 123.727 2.951 . . . . 0.0 112.14 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.287 . . . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.791 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 36.6 mt -85.21 104.74 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.253 0.549 . . . . 0.0 110.853 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -101.83 122.78 44.63 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.435 HG22 ' HE2' ' A' ' 22' ' ' TYR . 17.9 p -78.79 -5.04 52.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.538 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.5 t30 58.71 39.08 24.74 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 122.602 1.192 . . . . 0.0 109.016 -173.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.8 112.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.036 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -63.07 132.63 52.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 19.6 p -101.53 130.26 47.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.255 0.55 . . . . 0.0 112.114 -169.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -106.6 15.3 25.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.842 0.829 . . . . 0.0 108.783 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.08 137.74 2.28 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.537 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 15' ' ' VAL . 19.4 m -70.06 -26.65 64.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.177 0.489 . . . . 0.0 111.641 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -66.42 -43.07 86.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -170.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -33.92 75.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.282 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 10.2 m -67.13 -58.15 5.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.617 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 19' ' ' ILE . 2.4 p -57.55 -35.35 49.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.18 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.41 -52.92 55.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.226 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 20' ' ' ASP . 2.5 tp -81.43 -24.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.129 0.49 . . . . 0.0 111.528 -173.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 20.1 t -63.86 -24.48 67.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.37 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 15' ' ' VAL . 64.7 mt -74.96 -39.95 45.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.692 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.485 ' HB3' HD12 ' A' ' 17' ' ' ILE . 14.4 t70 -76.26 -39.43 54.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.269 0.557 . . . . 0.0 109.792 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 21' ' ' ARG . 33.7 mtt180 -67.46 -56.41 9.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.021 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.435 ' HE2' HG22 ' A' ' 4' ' ' THR . 59.1 m-85 -109.37 -101.87 0.38 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 -172.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -160.39 -15.08 0.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.218 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.457 HG21 ' HB3' ' A' ' 36' ' ' CYS . 4.7 t -101.47 163.92 12.02 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.329 -165.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.719 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -137.29 13.03 3.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.535 -167.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.67 79.37 0.37 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.58 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.17 141.16 47.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.024 0.44 . . . . 0.0 111.029 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -127.54 136.35 51.59 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.504 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 43.9 t -79.67 103.3 9.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.546 HG23 ' H ' ' A' ' 31' ' ' ASN . 4.9 tp -127.97 -64.34 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -169.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.546 ' H ' HG23 ' A' ' 30' ' ' ILE . 95.8 m-20 -95.77 33.71 1.62 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.047 0.451 . . . . 0.0 110.899 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.71 -12.86 67.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.716 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -133.48 169.67 16.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.874 0.369 . . . . 0.0 110.579 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 18.8 m -76.31 123.15 25.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.571 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -117.46 120.66 38.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.196 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.791 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 59.9 m -98.99 125.86 44.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.415 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -105.36 92.68 5.97 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.323 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 15.4 Cg_exo . . . . . 0 C--O 1.247 0.947 0 C-N-CA 123.45 2.767 . . . . 0.0 112.145 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.309 . . . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 77.3 mt -82.54 98.07 4.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.75 0.31 . . . . 0.0 110.658 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -108.48 129.23 55.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 6' ' ' VAL . 13.8 p -85.96 -0.03 54.45 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.456 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 62.8 t30 55.29 42.64 30.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 122.413 1.101 . . . . 0.0 109.265 -174.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 4' ' ' THR . 54.2 t -129.89 113.26 26.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.167 -1.378 . . . . 0.0 110.097 -174.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -51.62 138.36 22.99 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.754 0.659 . . . . 0.0 110.146 176.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 p -79.0 134.31 36.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.465 0.65 . . . . 0.0 111.598 -168.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 t -96.76 43.21 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.843 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.63 21.79 7.36 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.367 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.401 ' O ' HG23 ' A' ' 15' ' ' VAL . 91.5 p 65.46 -51.41 0.37 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.923 1.289 . . . . 0.0 113.267 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 t -63.22 -36.4 83.52 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.552 0.341 . . . . 0.0 111.877 -173.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -50.84 -45.58 59.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.153 0.501 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 1.5 m -67.49 -44.06 79.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.305 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.624 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 16.2 t -55.82 -40.14 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -74.28 -55.53 5.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.612 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 20' ' ' ASP . 2.8 tp -77.36 -28.0 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -169.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.436 ' SG ' HG21 ' A' ' 24' ' ' THR . 7.8 t -62.49 -26.41 68.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.974 0.416 . . . . 0.0 110.024 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 24' ' ' THR . 59.5 mt -71.74 -44.91 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.49 ' HB3' HD12 ' A' ' 17' ' ' ILE . 23.3 t70 -68.79 -36.06 77.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.232 0.539 . . . . 0.0 110.425 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.73 -45.32 25.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.101 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -121.81 -114.09 0.32 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.422 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -161.73 92.06 0.85 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.287 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.655 HG22 ' HG3' ' A' ' 38' ' ' PRO . 72.8 p -135.68 153.61 51.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.297 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -117.46 6.25 12.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.059 0.457 . . . . 0.0 109.811 174.177 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.87 127.96 1.36 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.479 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' A' ' 15' ' ' VAL . . . -128.75 159.35 35.96 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -149.54 155.76 40.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.196 0.522 . . . . 0.0 111.326 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.1 t -96.61 100.23 11.81 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 tp -99.52 -50.9 10.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.729 -170.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -115.65 19.7 15.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.781 0.8 . . . . 0.0 109.709 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.25 -7.37 32.56 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.709 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 10.7 ptt180 -131.31 170.94 13.94 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.585 -0.362 . . . . 0.0 110.888 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 32.7 m -75.73 123.25 25.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.538 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.5 m -126.16 122.2 35.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.486 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.682 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 34.2 m -98.07 136.46 38.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.303 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -117.48 84.23 18.3 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.686 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.655 ' HG3' HG22 ' A' ' 24' ' ' THR . 11.4 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.268 2.646 . . . . 0.0 111.655 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.28 . . . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.778 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 92.6 mt -99.8 115.55 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.71 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -98.9 131.67 44.81 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -79.7 -22.17 43.72 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.61 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 4.8 t-20 67.58 38.7 3.0 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.092 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.14 128.21 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.994 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 43.4 mtmt -64.99 145.17 56.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.6 p -114.57 152.99 30.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 p -78.69 -39.48 36.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.623 0.725 . . . . 0.0 109.681 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.73 169.08 31.17 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.498 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.583 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 15.8 p -57.82 -28.43 64.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.937 0.399 . . . . 0.0 111.533 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.578 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 47.9 t -73.78 -8.33 55.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.229 -174.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -65.86 -53.93 33.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.918 0.389 . . . . 0.0 110.937 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 1.2 m -77.17 -40.93 43.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.578 ' CG1' ' HA ' ' A' ' 12' ' ' SER . 6.0 p -57.71 -26.9 28.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -172.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -87.61 -40.89 13.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.288 178.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.654 HD12 ' HB3' ' A' ' 20' ' ' ASP . 4.5 tp -85.14 -27.17 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.231 0.539 . . . . 0.0 111.738 -172.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.7 t -60.75 -21.43 62.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.358 0.599 . . . . 0.0 109.826 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.2 mt -79.53 -29.96 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.075 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.654 ' HB3' HD12 ' A' ' 17' ' ' ILE . 30.3 t70 -85.32 -29.49 24.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.681 0.753 . . . . 0.0 109.945 -174.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 55.1 mtp180 -92.03 -43.86 9.18 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.226 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -110.05 -111.5 0.32 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.142 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -162.13 6.41 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 t -115.69 142.52 46.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.356 0.598 . . . . 0.0 111.797 -172.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -98.29 7.48 46.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.284 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.59 103.25 1.62 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.11 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -142.48 140.04 31.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.892 0.377 . . . . 0.0 110.762 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -138.01 142.7 40.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.204 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 82.1 m -80.2 133.42 36.02 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.437 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.2 tp -121.77 -55.79 3.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.947 -171.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.437 ' H ' HG23 ' A' ' 30' ' ' ILE . 15.8 t-20 -129.95 61.93 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.74 -26.07 2.05 Favored Glycine 0 CA--C 1.517 0.202 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.413 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.61 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 37.8 ttp180 -109.25 149.01 30.05 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 8.4 p -95.98 141.86 28.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 0.0 111.237 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.6 m -131.18 145.05 51.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.065 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.778 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 39.8 m -97.75 123.81 41.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.905 0.383 . . . . 0.0 110.306 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -116.6 85.87 17.55 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.161 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 17.9 Cg_exo . . . . . 0 C--O 1.248 1.014 0 C-N-CA 122.995 2.463 . . . . 0.0 111.521 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.862 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 77.9 mt . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.03 0.443 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -116.37 101.54 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.712 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 p -90.11 3.16 54.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.36 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t30 57.82 51.75 8.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 122.193 0.997 . . . . 0.0 109.693 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 85.9 t -124.57 118.6 53.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.705 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.17 148.29 48.46 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.506 0.503 . . . . 0.0 109.725 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.4 p -86.74 111.42 20.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.492 0.663 . . . . 0.0 111.536 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -86.43 32.91 0.63 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.18 128.83 4.94 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.53 -170.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 m -61.07 -19.02 60.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.071 0.436 . . . . 0.0 110.83 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.472 ' HA ' HG12 ' A' ' 15' ' ' VAL . 13.3 m -81.7 -5.84 58.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.763 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 17' ' ' ILE . 3.6 ttmp? -82.97 -51.19 7.8 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -62.39 -46.96 86.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.986 -178.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 12' ' ' SER . 7.1 p -57.67 -27.99 31.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.675 0.274 . . . . 0.0 111.524 -175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -88.97 -43.84 10.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.731 0.301 . . . . 0.0 111.174 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 14' ' ' CYS . 3.1 tp -82.29 -29.69 9.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.0 0.428 . . . . 0.0 112.031 -173.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.635 ' HA ' ' HD2' ' A' ' 21' ' ' ARG . 7.7 t -65.47 -20.24 66.27 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.061 0.458 . . . . 0.0 110.056 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 25' ' ' ARG . 66.5 mt -64.74 -39.46 85.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.312 173.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.63 -23.53 49.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.063 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.635 ' HD2' ' HA ' ' A' ' 18' ' ' CYS . 99.7 mtt180 -67.41 -67.43 0.46 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.267 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.11 -94.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.002 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -160.08 18.4 0.15 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 -174.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' A' ' 38' ' ' PRO . 8.4 t -103.73 161.1 14.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.05 0.452 . . . . 0.0 110.855 -173.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HA ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -124.39 10.15 8.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.465 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.57 119.29 1.46 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.04 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -141.16 144.56 34.89 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -141.64 145.59 35.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.994 0.426 . . . . 0.0 110.918 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 29.3 t -86.18 110.24 19.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -116.85 -46.57 3.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.474 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.527 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 27.3 p-10 -108.25 20.04 19.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.236 0.541 . . . . 0.0 110.603 -176.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.86 -6.07 54.15 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.057 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.527 ' HG2' ' OD1' ' A' ' 31' ' ' ASN . 11.4 ptp180 -130.95 167.99 18.08 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 14.9 m -89.98 113.08 24.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.8 m -112.55 135.67 53.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.573 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.862 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 17.7 m -99.7 130.78 45.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.798 0.332 . . . . 0.0 110.284 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -120.78 86.22 40.62 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.612 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 2.9 Cg_exo . . . . . 0 C--O 1.251 1.17 0 C-N-CA 123.149 2.566 . . . . 0.0 111.969 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.3 mt . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -103.46 125.49 50.07 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.7 p -75.63 -22.16 57.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.344 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 65.67 36.86 6.12 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.504 1.145 . . . . 0.0 108.65 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 3.2 t -135.8 114.47 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 112.929 -1.942 . . . . 0.0 110.222 -172.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 143.47 56.57 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.041 0.448 . . . . 0.0 110.319 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 p -122.22 160.6 24.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.644 -172.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 p -85.93 -48.65 8.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.276 172.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.54 162.55 25.46 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.781 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 20.5 m -62.13 -18.78 61.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.2 0.5 . . . . 0.0 111.346 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.419 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 15.5 p -64.68 -15.35 61.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.193 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -62.18 -55.2 31.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.921 0.391 . . . . 0.0 111.441 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.543 ' HA ' HG22 ' A' ' 17' ' ' ILE . 9.6 m -82.51 -41.67 19.41 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.433 ' N ' ' HB3' ' A' ' 27' ' ' ALA . 2.5 p -51.22 -33.64 13.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -172.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -46.43 10.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.753 0.311 . . . . 0.0 110.735 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 20' ' ' ASP . 3.5 tp -77.43 -29.55 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 111.937 -171.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -64.33 -15.91 61.21 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.776 178.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.9 mt -85.65 -25.53 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.153 0.502 . . . . 0.0 110.216 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.679 ' HB3' HD12 ' A' ' 17' ' ' ILE . 13.4 t70 -85.55 -32.89 21.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.473 0.654 . . . . 0.0 109.904 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.585 ' HD2' HG13 ' A' ' 17' ' ' ILE . 58.2 mtp180 -89.25 -41.92 11.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.728 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.27 -116.53 0.29 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -164.4 101.95 0.83 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.605 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.64 HG21 ' HB3' ' A' ' 36' ' ' CYS . 70.0 p -133.92 163.0 30.49 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.001 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -102.35 -39.22 7.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.61 150.86 23.15 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.291 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -141.31 137.21 32.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -126.39 139.28 53.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.998 0.428 . . . . 0.0 111.099 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.781 ' SG ' ' HA ' ' A' ' 11' ' ' SER . 56.0 m -79.83 107.05 12.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.51 173.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.5 tp -117.58 -45.25 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.05 -171.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -97.82 16.34 21.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.139 0.971 . . . . 0.0 109.873 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.65 -13.88 64.82 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 14.5 ptt180 -122.53 165.34 16.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.286 -0.957 . . . . 0.0 108.658 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 2.0 p -96.83 119.38 35.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.288 0.566 . . . . 0.0 111.715 -172.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.0 m -99.55 131.87 45.26 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.558 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.64 ' HB3' HG21 ' A' ' 24' ' ' THR . 29.5 m -98.5 135.78 39.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -113.91 90.63 19.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.105 0.479 . . . . 0.0 111.039 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 32.8 Cg_endo . . . . . 0 N--CA 1.444 -1.398 0 C-N-CA 124.395 3.397 . . . . 0.0 111.9 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.859 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 78.1 mt . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 120.635 0.255 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -122.65 122.57 39.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.079 0.466 . . . . 0.0 110.264 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 p -97.17 1.16 49.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.892 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.692 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 37.4 t30 52.98 71.71 0.47 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.966 0.888 . . . . 0.0 110.119 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.2 t -134.68 110.06 12.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.514 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 7' ' ' LYS . 23.8 mmmt -48.82 117.73 2.21 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.692 0.62 . . . . 0.0 110.232 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.1 p -83.0 145.84 29.1 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.108 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p -103.28 28.35 6.45 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.876 171.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.13 -113.54 0.94 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.782 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.1 p -164.38 -27.66 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.892 0.377 . . . . 0.0 110.385 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.432 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 10.7 p -60.59 -14.86 22.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.856 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 17' ' ' ILE . 4.7 tmtm? -69.12 -61.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.553 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -63.61 -48.72 76.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.45 -174.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.481 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 6.0 p -54.15 -33.51 25.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -86.36 -52.04 5.86 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.162 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.605 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 4.1 tp -72.03 -32.05 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -172.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 t -60.77 -24.19 65.58 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.977 0.417 . . . . 0.0 110.356 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.8 mt -69.72 -39.44 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.809 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.587 ' HB2' HD12 ' A' ' 17' ' ' ILE . 16.4 m-20 -77.41 -14.08 59.78 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.097 0.475 . . . . 0.0 110.65 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 49.0 mtm180 -98.65 -47.6 5.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.845 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -115.1 -109.11 0.36 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -161.85 15.57 0.09 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.067 0.461 . . . . 0.0 110.881 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 36' ' ' CYS . 6.4 t -104.54 139.84 38.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.994 0.426 . . . . 0.0 110.821 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.66 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -101.67 -2.65 29.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.643 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.9 97.87 0.84 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.994 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.553 ' HB1' ' HB2' ' A' ' 14' ' ' CYS . . . -131.88 131.35 42.68 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 29' ' ' CYS . 26.4 ttpt -133.36 148.93 51.87 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.116 -176.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 15.0 t -85.87 127.16 34.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 172.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.658 HG23 ' H ' ' A' ' 31' ' ' ASN . 4.3 tp -112.75 -71.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.729 -176.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.658 ' H ' HG23 ' A' ' 30' ' ' ILE . 21.6 t-20 -98.27 40.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.519 0.676 . . . . 0.0 109.922 -176.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.64 3.79 70.91 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.259 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.692 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 5.9 ptp180 -134.19 157.08 47.15 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 1.5 m -89.08 120.46 30.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.998 0.428 . . . . 0.0 111.499 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.0 m -123.29 139.91 53.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.726 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.859 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 32.8 m -99.07 132.29 44.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -119.93 83.76 30.89 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.136 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo . . . . . 0 C--O 1.246 0.92 0 C-N-CA 122.838 2.359 . . . . 0.0 111.711 177.491 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.871 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 87.5 mt . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.406 0.622 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -90.82 106.71 18.7 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 6' ' ' VAL . 24.8 p -75.37 -24.74 57.31 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.423 -173.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.8 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 66.2 t30 67.26 40.37 2.79 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 122.832 1.301 . . . . 0.0 107.664 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 5.1 t -124.04 126.83 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 112.999 -1.91 . . . . 0.0 109.747 -170.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -60.55 144.16 52.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.345 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.67 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 4.1 p -104.7 129.48 52.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.15 0.5 . . . . 0.0 111.905 -176.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 m -96.46 21.46 9.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.639 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.76 34.66 0.9 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.038 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.487 ' O ' HG12 ' A' ' 15' ' ' VAL . 68.7 m 71.46 -37.64 0.4 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.479 0.712 . . . . 0.0 112.9 175.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.568 ' HA ' HG12 ' A' ' 15' ' ' VAL . 22.0 t -62.4 -19.96 63.97 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.455 0.645 . . . . 0.0 109.909 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -57.22 -43.23 82.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.706 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -97.52 -49.24 4.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.283 -175.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 12' ' ' SER . 14.9 p -62.11 -8.95 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.367 0.603 . . . . 0.0 111.666 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -96.8 -51.49 4.26 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.997 -0.439 . . . . 0.0 110.703 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.633 HD12 ' HB3' ' A' ' 20' ' ' ASP . 1.7 tp -85.32 -32.85 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.1 t -62.85 -25.81 68.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.45 0.643 . . . . 0.0 109.704 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 24' ' ' THR . 1.7 mp -77.63 -33.4 19.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.404 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.633 ' HB3' HD12 ' A' ' 17' ' ' ILE . 8.5 t70 -76.17 -35.83 58.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.363 0.602 . . . . 0.0 109.64 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -75.35 -52.56 10.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.254 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -111.93 -113.57 0.33 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.113 0.483 . . . . 0.0 112.246 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -159.04 19.73 0.19 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.52 -170.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.658 ' O ' HG13 ' A' ' 19' ' ' ILE . 9.0 t -100.77 171.48 7.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.145 -174.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.5 -1.35 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.031 0.443 . . . . 0.0 110.347 173.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.76 67.62 0.36 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.49 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 14' ' ' CYS . . . -104.93 132.4 51.22 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -139.65 150.75 45.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.024 0.44 . . . . 0.0 111.506 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 38.9 t -80.79 106.79 13.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.48 HG21 ' OH ' ' A' ' 37' ' ' TYR . 3.7 tp -129.84 -46.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -167.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.443 ' ND2' HG23 ' A' ' 30' ' ' ILE . 55.7 m-80 -108.17 33.64 4.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.824 0.345 . . . . 0.0 110.854 -175.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.49 -5.98 62.5 Favored Glycine 0 CA--C 1.507 -0.411 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -172.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.8 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 19.4 ptt-85 -140.65 176.88 8.43 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.578 -0.811 . . . . 0.0 109.094 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.6 m -95.14 126.35 40.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.404 0.621 . . . . 0.0 112.278 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.0 m -119.95 132.16 55.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.222 174.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.871 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 38.7 m -100.04 125.59 46.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.299 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.48 ' OH ' HG21 ' A' ' 30' ' ' ILE . 32.9 m-85 -109.64 91.07 9.75 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.55 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 3.0 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.329 2.686 . . . . 0.0 111.798 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.794 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 1.6 mp . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 121.039 0.447 . . . . 0.0 110.981 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -113.06 100.41 8.59 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 170.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 6' ' ' VAL . 67.9 p -69.41 -23.06 63.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.455 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 59.83 32.86 21.52 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 122.094 0.949 . . . . 0.0 109.524 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 4' ' ' THR . 88.3 t -123.78 120.06 58.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.142 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 41.0 mtmt -49.42 139.97 11.09 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.214 0.946 . . . . 0.0 112.224 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 p -94.39 162.28 13.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.1 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.4 m -111.14 30.04 7.25 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.47 158.29 14.86 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.777 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.4 p -63.82 -21.9 66.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.231 0.515 . . . . 0.0 111.447 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.8 m -60.13 -28.75 68.14 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.451 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -72.69 -51.09 20.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.129 0.49 . . . . 0.0 109.99 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -63.48 -45.48 90.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.212 -175.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 12.3 p -62.78 -15.72 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.163 0.506 . . . . 0.0 111.387 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -102.88 -50.8 3.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.961 0.41 . . . . 0.0 110.423 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.521 HD12 ' HB3' ' A' ' 20' ' ' ASP . 3.0 tp -77.95 -22.5 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.74 -17.54 64.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.101 0.477 . . . . 0.0 110.102 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.29 -27.4 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.307 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.521 ' HB3' HD12 ' A' ' 17' ' ' ILE . 24.1 t70 -86.26 -44.84 11.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.246 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -69.32 -49.83 52.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.941 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.64 -111.71 0.33 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.933 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -161.59 12.92 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.447 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.557 HG21 ' HG3' ' A' ' 38' ' ' PRO . 22.9 p -119.95 129.52 54.35 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -165.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.667 ' HD2' ' N ' ' A' ' 26' ' ' GLY . 1.9 ppt_? -84.97 -11.14 56.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.082 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.667 ' N ' ' HD2' ' A' ' 25' ' ' ARG . . . -95.35 100.53 2.56 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.639 -175.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -140.96 142.42 34.34 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.903 0.382 . . . . 0.0 111.025 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -145.48 141.75 28.62 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.9 t -84.88 112.66 20.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.583 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.4 tp -99.07 -63.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.583 ' H ' HG23 ' A' ' 30' ' ' ILE . 23.9 p-10 -105.38 17.1 24.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.419 0.628 . . . . 0.0 110.204 -174.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 104.57 -5.75 44.39 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.598 -176.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 17.5 mmt-85 -108.38 172.45 6.83 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 47.9 m -91.2 110.64 21.93 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.903 175.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 84.9 m -117.86 131.36 56.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.223 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.794 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 28.4 m -106.1 134.74 48.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.597 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -118.83 87.88 34.23 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.729 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HG3' HG21 ' A' ' 24' ' ' THR . 8.4 Cg_exo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.723 2.949 . . . . 0.0 112.549 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.823 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 47.5 mm . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 121.027 0.442 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -98.83 109.66 22.38 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.7 p -74.47 -13.68 60.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.861 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 60.0 39.79 19.54 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 109.969 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 69.3 t -115.86 104.53 16.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.237 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 48.1 mtpt -52.76 121.07 6.51 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.969 176.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.5 p -139.67 148.88 43.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.759 -176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 p -94.42 -51.28 4.84 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.15 123.37 7.91 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.761 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.831 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 34.8 m -62.18 -24.21 67.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 111.612 -177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.499 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 32.8 t -66.19 -30.63 71.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.077 -168.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -69.16 -15.83 63.5 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.129 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.445 ' HA ' HG22 ' A' ' 17' ' ' ILE . 72.7 m -102.93 -39.94 6.73 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.822 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 1.4 p -58.21 -35.69 54.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.427 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -72.62 -40.59 66.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.774 0.321 . . . . 0.0 111.355 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 14' ' ' CYS . 4.5 tp -86.39 -32.71 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.0 t -56.61 -26.91 57.01 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.035 0.445 . . . . 0.0 110.399 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 15' ' ' VAL . 78.1 mt -60.28 -41.0 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.408 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -85.1 -23.04 28.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.424 0.63 . . . . 0.0 110.481 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.96 -55.45 5.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.949 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.54 -108.07 0.33 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.505 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -161.21 18.18 0.11 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.975 0.417 . . . . 0.0 110.748 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.53 HG21 ' HB3' ' A' ' 36' ' ' CYS . 2.9 t -120.0 162.99 18.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 -173.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.699 ' HD3' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -126.17 2.49 7.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.309 -173.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.05 71.37 0.32 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.76 -174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' A' ' 15' ' ' VAL . . . -99.05 144.97 27.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.911 0.386 . . . . 0.0 110.188 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -147.78 141.95 26.11 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.926 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.831 ' SG ' ' HA ' ' A' ' 11' ' ' SER . 70.2 m -79.43 100.62 7.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.726 HG23 ' H ' ' A' ' 31' ' ' ASN . 6.1 tp -98.46 -66.09 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.757 -170.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.726 ' H ' HG23 ' A' ' 30' ' ' ILE . 92.4 m-20 -96.64 34.98 1.57 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.28 4.66 89.46 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.402 -174.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.5 mmt85 -128.75 157.96 39.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 m -77.18 112.76 14.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.531 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 61.4 m -116.98 128.06 54.81 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.823 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 46.3 m -99.13 128.02 45.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.346 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -110.95 92.52 15.07 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.183 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 10.2 Cg_exo . . . . . 0 C--O 1.25 1.092 0 C-N-CA 123.227 2.618 . . . . 0.0 111.742 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.741 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 34.0 mm . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 120.843 0.354 . . . . 0.0 110.23 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -90.14 100.34 13.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -72.89 -11.65 60.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.068 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.78 46.1 14.64 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.909 0.861 . . . . 0.0 109.643 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 74.2 t -119.83 103.69 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.416 -173.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 7' ' ' LYS . 27.0 mtmm -56.07 120.98 8.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.602 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.9 p -133.53 160.72 36.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.344 0.592 . . . . 0.0 112.17 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.8 m -121.8 -0.2 9.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.446 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.75 143.41 10.75 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.248 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 15' ' ' VAL . 10.7 m -90.56 -26.76 19.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.627 0.251 . . . . 0.0 111.257 -177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 t -60.62 -42.54 97.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.061 -170.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -63.79 -29.18 70.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.772 0.32 . . . . 0.0 110.987 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.55 ' HA ' HG22 ' A' ' 17' ' ' ILE . 98.8 m -85.08 -46.01 11.56 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.673 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 2.6 p -59.71 -33.57 52.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.623 0.249 . . . . 0.0 111.454 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -79.14 -36.49 40.44 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.057 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 20' ' ' ASP . 4.0 tp -85.48 -23.11 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.147 0.499 . . . . 0.0 111.405 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.704 ' SG ' HG23 ' A' ' 24' ' ' THR . 41.8 t -63.3 -20.52 65.55 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.14 0.495 . . . . 0.0 110.106 176.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.8 mt -75.41 -32.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.463 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.643 ' HB3' HD12 ' A' ' 17' ' ' ILE . 12.4 t70 -83.89 -43.9 14.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.339 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.52 -38.74 81.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.946 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -123.07 -109.38 0.33 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -162.51 4.62 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.053 0.454 . . . . 0.0 111.152 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.704 HG23 ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -105.76 154.52 20.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.17 0.51 . . . . 0.0 111.415 -170.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -118.29 16.42 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.808 -168.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.2 55.43 0.74 Allowed Glycine 0 C--O 1.224 -0.503 0 C-N-CA 119.684 -1.246 . . . . 0.0 113.554 -173.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.732 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -97.89 130.51 44.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.278 0.539 . . . . 0.0 111.044 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 84.8 tttt -130.47 140.72 50.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.413 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.0 t -81.69 92.29 6.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.473 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.2 tp -116.96 -58.37 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -168.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.473 ' H ' HG23 ' A' ' 30' ' ' ILE . 4.3 t30 -95.18 40.74 1.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.533 0.682 . . . . 0.0 109.516 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.98 -0.52 72.36 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.142 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 7.3 ptp180 -141.13 165.3 27.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 63.3 m -83.3 106.49 15.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.8 m -100.49 126.72 46.94 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.741 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -99.76 122.65 43.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.079 -176.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -106.31 96.15 12.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.569 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 8.2 Cg_exo . . . . . 0 C--O 1.25 1.079 0 C-N-CA 123.727 2.951 . . . . 0.0 112.14 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.791 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 36.6 mt . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 121.253 0.549 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -101.83 122.78 44.63 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.435 HG22 ' HE2' ' A' ' 22' ' ' TYR . 17.9 p -78.79 -5.04 52.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.538 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.5 t30 58.71 39.08 24.74 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 122.602 1.192 . . . . 0.0 109.016 -173.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.8 112.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.036 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -63.07 132.63 52.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 19.6 p -101.53 130.26 47.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.255 0.55 . . . . 0.0 112.114 -169.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -106.6 15.3 25.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.842 0.829 . . . . 0.0 108.783 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.08 137.74 2.28 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.537 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 15' ' ' VAL . 19.4 m -70.06 -26.65 64.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.177 0.489 . . . . 0.0 111.641 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -66.42 -43.07 86.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -170.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -33.92 75.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.282 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 10.2 m -67.13 -58.15 5.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.617 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 19' ' ' ILE . 2.4 p -57.55 -35.35 49.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.18 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.41 -52.92 55.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.226 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 20' ' ' ASP . 2.5 tp -81.43 -24.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.129 0.49 . . . . 0.0 111.528 -173.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 20.1 t -63.86 -24.48 67.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.37 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 15' ' ' VAL . 64.7 mt -74.96 -39.95 45.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.692 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.485 ' HB3' HD12 ' A' ' 17' ' ' ILE . 14.4 t70 -76.26 -39.43 54.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.269 0.557 . . . . 0.0 109.792 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 21' ' ' ARG . 33.7 mtt180 -67.46 -56.41 9.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.021 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.435 ' HE2' HG22 ' A' ' 4' ' ' THR . 59.1 m-85 -109.37 -101.87 0.38 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 -172.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -160.39 -15.08 0.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.218 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.457 HG21 ' HB3' ' A' ' 36' ' ' CYS . 4.7 t -101.47 163.92 12.02 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.329 -165.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.719 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -137.29 13.03 3.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.535 -167.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.67 79.37 0.37 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.58 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.17 141.16 47.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.024 0.44 . . . . 0.0 111.029 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -127.54 136.35 51.59 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.504 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 43.9 t -79.67 103.3 9.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.546 HG23 ' H ' ' A' ' 31' ' ' ASN . 4.9 tp -127.97 -64.34 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -169.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.546 ' H ' HG23 ' A' ' 30' ' ' ILE . 95.8 m-20 -95.77 33.71 1.62 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.047 0.451 . . . . 0.0 110.899 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.71 -12.86 67.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.716 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -133.48 169.67 16.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.874 0.369 . . . . 0.0 110.579 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 18.8 m -76.31 123.15 25.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.571 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -117.46 120.66 38.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.196 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.791 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 59.9 m -98.99 125.86 44.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.415 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -105.36 92.68 5.97 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.323 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 15.4 Cg_exo . . . . . 0 C--O 1.247 0.947 0 C-N-CA 123.45 2.767 . . . . 0.0 112.145 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 77.3 mt . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.75 0.31 . . . . 0.0 110.658 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -108.48 129.23 55.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 6' ' ' VAL . 13.8 p -85.96 -0.03 54.45 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.456 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 62.8 t30 55.29 42.64 30.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 122.413 1.101 . . . . 0.0 109.265 -174.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 4' ' ' THR . 54.2 t -129.89 113.26 26.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.167 -1.378 . . . . 0.0 110.097 -174.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -51.62 138.36 22.99 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.754 0.659 . . . . 0.0 110.146 176.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 p -79.0 134.31 36.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.465 0.65 . . . . 0.0 111.598 -168.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 t -96.76 43.21 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.843 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.63 21.79 7.36 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.367 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.401 ' O ' HG23 ' A' ' 15' ' ' VAL . 91.5 p 65.46 -51.41 0.37 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.923 1.289 . . . . 0.0 113.267 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 t -63.22 -36.4 83.52 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.552 0.341 . . . . 0.0 111.877 -173.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -50.84 -45.58 59.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.153 0.501 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 1.5 m -67.49 -44.06 79.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.305 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.624 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 16.2 t -55.82 -40.14 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -74.28 -55.53 5.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.612 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 20' ' ' ASP . 2.8 tp -77.36 -28.0 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -169.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.436 ' SG ' HG21 ' A' ' 24' ' ' THR . 7.8 t -62.49 -26.41 68.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.974 0.416 . . . . 0.0 110.024 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 24' ' ' THR . 59.5 mt -71.74 -44.91 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.49 ' HB3' HD12 ' A' ' 17' ' ' ILE . 23.3 t70 -68.79 -36.06 77.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.232 0.539 . . . . 0.0 110.425 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.73 -45.32 25.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.101 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -121.81 -114.09 0.32 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.422 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -161.73 92.06 0.85 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.287 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.655 HG22 ' HG3' ' A' ' 38' ' ' PRO . 72.8 p -135.68 153.61 51.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.297 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -117.46 6.25 12.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.059 0.457 . . . . 0.0 109.811 174.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.87 127.96 1.36 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.479 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' A' ' 15' ' ' VAL . . . -128.75 159.35 35.96 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -149.54 155.76 40.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.196 0.522 . . . . 0.0 111.326 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.1 t -96.61 100.23 11.81 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 tp -99.52 -50.9 10.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.729 -170.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -115.65 19.7 15.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.781 0.8 . . . . 0.0 109.709 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.25 -7.37 32.56 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.709 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 10.7 ptt180 -131.31 170.94 13.94 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.585 -0.362 . . . . 0.0 110.888 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 32.7 m -75.73 123.25 25.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.538 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.5 m -126.16 122.2 35.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.486 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.682 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 34.2 m -98.07 136.46 38.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.303 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -117.48 84.23 18.3 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.686 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.655 ' HG3' HG22 ' A' ' 24' ' ' THR . 11.4 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.268 2.646 . . . . 0.0 111.655 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.778 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 92.6 mt . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.634 0.254 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -98.9 131.67 44.81 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -79.7 -22.17 43.72 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.61 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 4.8 t-20 67.58 38.7 3.0 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.092 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.14 128.21 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.994 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 43.4 mtmt -64.99 145.17 56.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.6 p -114.57 152.99 30.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 p -78.69 -39.48 36.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.623 0.725 . . . . 0.0 109.681 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.73 169.08 31.17 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.498 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.583 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 15.8 p -57.82 -28.43 64.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.937 0.399 . . . . 0.0 111.533 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.578 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 47.9 t -73.78 -8.33 55.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.229 -174.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -65.86 -53.93 33.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.918 0.389 . . . . 0.0 110.937 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 1.2 m -77.17 -40.93 43.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.578 ' CG1' ' HA ' ' A' ' 12' ' ' SER . 6.0 p -57.71 -26.9 28.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -172.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -87.61 -40.89 13.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.288 178.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.654 HD12 ' HB3' ' A' ' 20' ' ' ASP . 4.5 tp -85.14 -27.17 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.231 0.539 . . . . 0.0 111.738 -172.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.7 t -60.75 -21.43 62.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.358 0.599 . . . . 0.0 109.826 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.2 mt -79.53 -29.96 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.075 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.654 ' HB3' HD12 ' A' ' 17' ' ' ILE . 30.3 t70 -85.32 -29.49 24.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.681 0.753 . . . . 0.0 109.945 -174.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 55.1 mtp180 -92.03 -43.86 9.18 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.226 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -110.05 -111.5 0.32 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.142 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -162.13 6.41 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 t -115.69 142.52 46.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.356 0.598 . . . . 0.0 111.797 -172.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -98.29 7.48 46.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.284 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.59 103.25 1.62 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.11 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -142.48 140.04 31.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.892 0.377 . . . . 0.0 110.762 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -138.01 142.7 40.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.204 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 82.1 m -80.2 133.42 36.02 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.437 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.2 tp -121.77 -55.79 3.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.947 -171.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.437 ' H ' HG23 ' A' ' 30' ' ' ILE . 15.8 t-20 -129.95 61.93 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.74 -26.07 2.05 Favored Glycine 0 CA--C 1.517 0.202 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.413 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.61 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 37.8 ttp180 -109.25 149.01 30.05 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 8.4 p -95.98 141.86 28.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 0.0 111.237 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.6 m -131.18 145.05 51.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.065 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.778 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 39.8 m -97.75 123.81 41.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.905 0.383 . . . . 0.0 110.306 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -116.6 85.87 17.55 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.161 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 17.9 Cg_exo . . . . . 0 C--O 1.248 1.014 0 C-N-CA 122.995 2.463 . . . . 0.0 111.521 176.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.271 . . . . . . . 0 N--CA 1.479 0.994 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.862 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 77.9 mt -83.88 101.81 8.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.03 0.443 . . . . 0.0 110.94 -178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -116.37 101.54 8.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.712 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 p -90.11 3.16 54.19 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.36 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.9 t30 57.82 51.75 8.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 122.193 0.997 . . . . 0.0 109.693 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 85.9 t -124.57 118.6 53.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.705 -176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.17 148.29 48.46 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 123.506 0.503 . . . . 0.0 109.725 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.4 p -86.74 111.42 20.69 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.492 0.663 . . . . 0.0 111.536 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -86.43 32.91 0.63 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.18 128.83 4.94 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.53 -170.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.7 m -61.07 -19.02 60.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.071 0.436 . . . . 0.0 110.83 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.472 ' HA ' HG12 ' A' ' 15' ' ' VAL . 13.3 m -81.7 -5.84 58.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.763 -176.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.405 ' O ' HG22 ' A' ' 17' ' ' ILE . 3.6 ttmp? -82.97 -51.19 7.8 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.439 ' HB2' ' CB ' ' A' ' 27' ' ' ALA . 0.4 OUTLIER -62.39 -46.96 86.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.986 -178.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 12' ' ' SER . 7.1 p -57.67 -27.99 31.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.675 0.274 . . . . 0.0 111.524 -175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -88.97 -43.84 10.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.731 0.301 . . . . 0.0 111.174 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 14' ' ' CYS . 3.1 tp -82.29 -29.69 9.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.0 0.428 . . . . 0.0 112.031 -173.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.635 ' HA ' ' HD2' ' A' ' 21' ' ' ARG . 7.7 t -65.47 -20.24 66.27 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.061 0.458 . . . . 0.0 110.056 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.439 HG12 ' HA ' ' A' ' 25' ' ' ARG . 66.5 mt -64.74 -39.46 85.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.312 173.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -77.63 -23.53 49.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.063 -177.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.635 ' HD2' ' HA ' ' A' ' 18' ' ' CYS . 99.7 mtt180 -67.41 -67.43 0.46 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.267 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.11 -94.35 0.49 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.002 -171.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -160.08 18.4 0.15 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.925 0.393 . . . . 0.0 110.807 -174.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' A' ' 38' ' ' PRO . 8.4 t -103.73 161.1 14.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.05 0.452 . . . . 0.0 110.855 -173.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.439 ' HA ' HG12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -124.39 10.15 8.55 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.465 178.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -141.57 119.29 1.46 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.169 -1.015 . . . . 0.0 113.04 -174.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -141.16 144.56 34.89 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -141.64 145.59 35.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.994 0.426 . . . . 0.0 110.918 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 29.3 t -86.18 110.24 19.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 171.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.7 tp -116.85 -46.57 3.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.474 -174.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.527 ' OD1' ' HG2' ' A' ' 33' ' ' ARG . 27.3 p-10 -108.25 20.04 19.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.236 0.541 . . . . 0.0 110.603 -176.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.86 -6.07 54.15 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.057 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.527 ' HG2' ' OD1' ' A' ' 31' ' ' ASN . 11.4 ptp180 -130.95 167.99 18.08 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 14.9 m -89.98 113.08 24.68 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.8 m -112.55 135.67 53.0 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.573 177.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.862 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 17.7 m -99.7 130.78 45.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.798 0.332 . . . . 0.0 110.284 -177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -120.78 86.22 40.62 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.612 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 2.9 Cg_exo . . . . . 0 C--O 1.251 1.17 0 C-N-CA 123.149 2.566 . . . . 0.0 111.969 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.269 . . . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.3 mt -125.07 124.41 67.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.141 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -103.46 125.49 50.07 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.7 p -75.63 -22.16 57.08 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.344 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.3 m120 65.67 36.86 6.12 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 122.504 1.145 . . . . 0.0 108.65 178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.503 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 3.2 t -135.8 114.47 15.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 112.929 -1.942 . . . . 0.0 110.222 -172.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 143.47 56.57 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.041 0.448 . . . . 0.0 110.319 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.8 p -122.22 160.6 24.87 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.644 -172.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.1 p -85.93 -48.65 8.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.276 172.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.54 162.55 25.46 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.781 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 20.5 m -62.13 -18.78 61.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.2 0.5 . . . . 0.0 111.346 -176.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.419 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 15.5 p -64.68 -15.35 61.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.193 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.9 tmtt? -62.18 -55.2 31.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.921 0.391 . . . . 0.0 111.441 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.543 ' HA ' HG22 ' A' ' 17' ' ' ILE . 9.6 m -82.51 -41.67 19.41 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.433 ' N ' ' HB3' ' A' ' 27' ' ' ALA . 2.5 p -51.22 -33.64 13.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -172.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -46.43 10.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.753 0.311 . . . . 0.0 110.735 178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 20' ' ' ASP . 3.5 tp -77.43 -29.55 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.978 0.418 . . . . 0.0 111.937 -171.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -64.33 -15.91 61.21 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.776 178.015 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.9 mt -85.65 -25.53 6.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.153 0.502 . . . . 0.0 110.216 175.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.679 ' HB3' HD12 ' A' ' 17' ' ' ILE . 13.4 t70 -85.55 -32.89 21.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.473 0.654 . . . . 0.0 109.904 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.585 ' HD2' HG13 ' A' ' 17' ' ' ILE . 58.2 mtp180 -89.25 -41.92 11.92 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.728 -178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -124.27 -116.53 0.29 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -164.4 101.95 0.83 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.605 176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.64 HG21 ' HB3' ' A' ' 36' ' ' CYS . 70.0 p -133.92 163.0 30.49 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.235 -0.186 . . . . 0.0 111.001 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -102.35 -39.22 7.27 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -147.61 150.86 23.15 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.291 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' HB3' ' N ' ' A' ' 15' ' ' VAL . . . -141.31 137.21 32.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -126.39 139.28 53.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.998 0.428 . . . . 0.0 111.099 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.781 ' SG ' ' HA ' ' A' ' 11' ' ' SER . 56.0 m -79.83 107.05 12.31 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.51 173.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.5 tp -117.58 -45.25 3.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.05 -171.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -97.82 16.34 21.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.139 0.971 . . . . 0.0 109.873 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.65 -13.88 64.82 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 14.5 ptt180 -122.53 165.34 16.56 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 114.286 -0.957 . . . . 0.0 108.658 173.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.596 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 2.0 p -96.83 119.38 35.21 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.288 0.566 . . . . 0.0 111.715 -172.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.0 m -99.55 131.87 45.26 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.558 176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.64 ' HB3' HG21 ' A' ' 24' ' ' THR . 29.5 m -98.5 135.78 39.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.73 -0.471 . . . . 0.0 109.73 -176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -113.91 90.63 19.62 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-O 121.105 0.479 . . . . 0.0 111.039 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 32.8 Cg_endo . . . . . 0 N--CA 1.444 -1.398 0 C-N-CA 124.395 3.397 . . . . 0.0 111.9 176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.292 . . . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.859 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 78.1 mt -91.38 102.43 13.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.46 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -122.65 122.57 39.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.079 0.466 . . . . 0.0 110.264 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.4 p -97.17 1.16 49.5 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.892 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.692 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . 37.4 t30 52.98 71.71 0.47 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.966 0.888 . . . . 0.0 110.119 -177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 77.2 t -134.68 110.06 12.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.514 -173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 7' ' ' LYS . 23.8 mmmt -48.82 117.73 2.21 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.692 0.62 . . . . 0.0 110.232 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 19.1 p -83.0 145.84 29.1 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.108 -171.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p -103.28 28.35 6.45 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.11 -0.95 . . . . 0.0 108.876 171.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.13 -113.54 0.94 Allowed Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.782 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.1 p -164.38 -27.66 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.892 0.377 . . . . 0.0 110.385 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.432 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 10.7 p -60.59 -14.86 22.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.856 178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 17' ' ' ILE . 4.7 tmtm? -69.12 -61.83 1.63 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.553 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 0.6 OUTLIER -63.61 -48.72 76.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.45 -174.474 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.481 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 6.0 p -54.15 -33.51 25.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -174.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -86.36 -52.04 5.86 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.162 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.605 ' O ' ' HG3' ' A' ' 21' ' ' ARG . 4.1 tp -72.03 -32.05 42.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -172.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 t -60.77 -24.19 65.58 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.977 0.417 . . . . 0.0 110.356 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.8 mt -69.72 -39.44 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.809 175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.587 ' HB2' HD12 ' A' ' 17' ' ' ILE . 16.4 m-20 -77.41 -14.08 59.78 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.097 0.475 . . . . 0.0 110.65 -175.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.605 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 49.0 mtm180 -98.65 -47.6 5.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.845 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -115.1 -109.11 0.36 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -176.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -161.85 15.57 0.09 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.067 0.461 . . . . 0.0 110.881 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 36' ' ' CYS . 6.4 t -104.54 139.84 38.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.994 0.426 . . . . 0.0 110.821 -175.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.66 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -101.67 -2.65 29.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.643 -177.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -114.9 97.87 0.84 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.994 -175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.553 ' HB1' ' HB2' ' A' ' 14' ' ' CYS . . . -131.88 131.35 42.68 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.418 ' HG2' ' N ' ' A' ' 29' ' ' CYS . 26.4 ttpt -133.36 148.93 51.87 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.116 -176.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 33' ' ' ARG . 15.0 t -85.87 127.16 34.52 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 172.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.658 HG23 ' H ' ' A' ' 31' ' ' ASN . 4.3 tp -112.75 -71.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.729 -176.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.658 ' H ' HG23 ' A' ' 30' ' ' ILE . 21.6 t-20 -98.27 40.37 1.19 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.519 0.676 . . . . 0.0 109.922 -176.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.64 3.79 70.91 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.259 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.692 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 5.9 ptp180 -134.19 157.08 47.15 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 178.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 1.5 m -89.08 120.46 30.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.998 0.428 . . . . 0.0 111.499 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.0 m -123.29 139.91 53.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.726 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.859 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 32.8 m -99.07 132.29 44.48 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -177.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -119.93 83.76 30.89 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.136 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo . . . . . 0 C--O 1.246 0.92 0 C-N-CA 122.838 2.359 . . . . 0.0 111.711 177.491 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.277 . . . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.871 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 87.5 mt -87.28 84.84 2.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.406 0.622 . . . . 0.0 110.116 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -90.82 106.71 18.7 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.428 ' OG1' ' HB ' ' A' ' 6' ' ' VAL . 24.8 p -75.37 -24.74 57.31 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.423 -173.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.8 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 66.2 t30 67.26 40.37 2.79 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 122.832 1.301 . . . . 0.0 107.664 -176.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.476 ' O ' ' HB2' ' A' ' 33' ' ' ARG . 5.1 t -124.04 126.83 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 CA-C-N 112.999 -1.91 . . . . 0.0 109.747 -170.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -60.55 144.16 52.14 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.345 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.67 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 4.1 p -104.7 129.48 52.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.15 0.5 . . . . 0.0 111.905 -176.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 m -96.46 21.46 9.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.639 176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.76 34.66 0.9 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.474 -0.87 . . . . 0.0 113.038 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.487 ' O ' HG12 ' A' ' 15' ' ' VAL . 68.7 m 71.46 -37.64 0.4 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.479 0.712 . . . . 0.0 112.9 175.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.568 ' HA ' HG12 ' A' ' 15' ' ' VAL . 22.0 t -62.4 -19.96 63.97 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.455 0.645 . . . . 0.0 109.909 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.1 tptp -57.22 -43.23 82.65 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.706 173.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.606 ' HB2' ' HB1' ' A' ' 27' ' ' ALA . 0.8 OUTLIER -97.52 -49.24 4.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.283 -175.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 12' ' ' SER . 14.9 p -62.11 -8.95 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 121.367 0.603 . . . . 0.0 111.666 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -96.8 -51.49 4.26 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.997 -0.439 . . . . 0.0 110.703 174.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.633 HD12 ' HB3' ' A' ' 20' ' ' ASP . 1.7 tp -85.32 -32.85 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -172.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 5.1 t -62.85 -25.81 68.46 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.45 0.643 . . . . 0.0 109.704 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 24' ' ' THR . 1.7 mp -77.63 -33.4 19.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.404 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.633 ' HB3' HD12 ' A' ' 17' ' ' ILE . 8.5 t70 -76.17 -35.83 58.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.363 0.602 . . . . 0.0 109.64 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -75.35 -52.56 10.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.254 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -111.93 -113.57 0.33 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 121.113 0.483 . . . . 0.0 112.246 -169.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -159.04 19.73 0.19 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.52 -170.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.658 ' O ' HG13 ' A' ' 19' ' ' ILE . 9.0 t -100.77 171.48 7.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.145 -174.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.5 -1.35 1.16 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.031 0.443 . . . . 0.0 110.347 173.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -118.76 67.62 0.36 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.475 -0.869 . . . . 0.0 112.49 -176.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.606 ' HB1' ' HB2' ' A' ' 14' ' ' CYS . . . -104.93 132.4 51.22 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -139.65 150.75 45.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.024 0.44 . . . . 0.0 111.506 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 38.9 t -80.79 106.79 13.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 171.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.48 HG21 ' OH ' ' A' ' 37' ' ' TYR . 3.7 tp -129.84 -46.75 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -167.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.443 ' ND2' HG23 ' A' ' 30' ' ' ILE . 55.7 m-80 -108.17 33.64 4.02 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.824 0.345 . . . . 0.0 110.854 -175.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.49 -5.98 62.5 Favored Glycine 0 CA--C 1.507 -0.411 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -172.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.8 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 19.4 ptt-85 -140.65 176.88 8.43 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.578 -0.811 . . . . 0.0 109.094 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 2.6 m -95.14 126.35 40.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.404 0.621 . . . . 0.0 112.278 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.0 m -119.95 132.16 55.43 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.195 -0.912 . . . . 0.0 109.222 174.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.871 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 38.7 m -100.04 125.59 46.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.299 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.48 ' OH ' HG21 ' A' ' 30' ' ' ILE . 32.9 m-85 -109.64 91.07 9.75 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.55 -177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 3.0 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.329 2.686 . . . . 0.0 111.798 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.278 . . . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.794 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 1.6 mp -68.19 110.09 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.981 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -113.06 100.41 8.59 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 170.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 6' ' ' VAL . 67.9 p -69.41 -23.06 63.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.455 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 59.83 32.86 21.52 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 122.094 0.949 . . . . 0.0 109.524 -174.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 4' ' ' THR . 88.3 t -123.78 120.06 58.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.142 -176.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 41.0 mtmt -49.42 139.97 11.09 Favored 'General case' 0 C--N 1.319 -0.754 0 O-C-N 124.214 0.946 . . . . 0.0 112.224 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 15.4 p -94.39 162.28 13.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.1 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.4 m -111.14 30.04 7.25 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 168.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.47 158.29 14.86 Favored Glycine 0 N--CA 1.441 -1.013 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.777 -166.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.4 p -63.82 -21.9 66.65 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 117.231 0.515 . . . . 0.0 111.447 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.8 m -60.13 -28.75 68.14 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.451 -176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -72.69 -51.09 20.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.129 0.49 . . . . 0.0 109.99 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 0.0 OUTLIER -63.48 -45.48 90.58 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.212 -175.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 12.3 p -62.78 -15.72 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.163 0.506 . . . . 0.0 111.387 -177.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.7 tmmm? -102.88 -50.8 3.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.961 0.41 . . . . 0.0 110.423 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.521 HD12 ' HB3' ' A' ' 20' ' ' ASP . 3.0 tp -77.95 -22.5 13.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -171.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.7 t -66.74 -17.54 64.91 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.101 0.477 . . . . 0.0 110.102 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.29 -27.4 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.307 176.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.521 ' HB3' HD12 ' A' ' 17' ' ' ILE . 24.1 t70 -86.26 -44.84 11.81 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.246 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -69.32 -49.83 52.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.941 -178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -110.64 -111.71 0.33 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 116.024 -0.535 . . . . 0.0 109.933 -176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -161.59 12.92 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.447 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.557 HG21 ' HG3' ' A' ' 38' ' ' PRO . 22.9 p -119.95 129.52 54.35 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -165.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.667 ' HD2' ' N ' ' A' ' 26' ' ' GLY . 1.9 ppt_? -84.97 -11.14 56.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.082 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.667 ' N ' ' HD2' ' A' ' 25' ' ' ARG . . . -95.35 100.53 2.56 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.639 -175.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -140.96 142.42 34.34 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.903 0.382 . . . . 0.0 111.025 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -145.48 141.75 28.62 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 50.9 t -84.88 112.66 20.75 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.583 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.4 tp -99.07 -63.6 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.583 ' H ' HG23 ' A' ' 30' ' ' ILE . 23.9 p-10 -105.38 17.1 24.5 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.419 0.628 . . . . 0.0 110.204 -174.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 104.57 -5.75 44.39 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.598 -176.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 7' ' ' LYS . 17.5 mmt-85 -108.38 172.45 6.83 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 175.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 47.9 m -91.2 110.64 21.93 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.903 175.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 84.9 m -117.86 131.36 56.55 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.223 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.794 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 28.4 m -106.1 134.74 48.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.036 0.446 . . . . 0.0 110.597 -176.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -118.83 87.88 34.23 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.729 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HG3' HG21 ' A' ' 24' ' ' THR . 8.4 Cg_exo . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.723 2.949 . . . . 0.0 112.549 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.281 . . . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.823 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 47.5 mm -82.65 86.98 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.027 0.442 . . . . 0.0 110.27 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -98.83 109.66 22.38 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.7 p -74.47 -13.68 60.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.861 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 60.0 39.79 19.54 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-O 121.604 0.716 . . . . 0.0 109.969 -178.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.606 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 69.3 t -115.86 104.53 16.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.237 -173.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 32' ' ' GLY . 48.1 mtpt -52.76 121.07 6.51 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.969 176.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 7.5 p -139.67 148.88 43.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.759 -176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 p -94.42 -51.28 4.84 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.15 123.37 7.91 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.761 176.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.831 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 34.8 m -62.18 -24.21 67.06 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 111.612 -177.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.499 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 32.8 t -66.19 -30.63 71.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.462 -0.79 . . . . 0.0 113.077 -168.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -69.16 -15.83 63.5 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.129 -176.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.445 ' HA ' HG22 ' A' ' 17' ' ' ILE . 72.7 m -102.93 -39.94 6.73 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.822 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 1.4 p -58.21 -35.69 54.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 121.261 -0.176 . . . . 0.0 111.427 -178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -72.62 -40.59 66.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.774 0.321 . . . . 0.0 111.355 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 14' ' ' CYS . 4.5 tp -86.39 -32.71 6.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 51.0 t -56.61 -26.91 57.01 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.035 0.445 . . . . 0.0 110.399 177.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 15' ' ' VAL . 78.1 mt -60.28 -41.0 85.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.408 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -85.1 -23.04 28.66 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.424 0.63 . . . . 0.0 110.481 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -76.96 -55.45 5.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.949 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -108.54 -108.07 0.33 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.505 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -161.21 18.18 0.11 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.975 0.417 . . . . 0.0 110.748 -177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.53 HG21 ' HB3' ' A' ' 36' ' ' CYS . 2.9 t -120.0 162.99 18.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.944 -173.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.699 ' HD3' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -126.17 2.49 7.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.309 -173.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -119.05 71.37 0.32 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.76 -174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.822 ' HB3' ' HA ' ' A' ' 15' ' ' VAL . . . -99.05 144.97 27.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.911 0.386 . . . . 0.0 110.188 176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -147.78 141.95 26.11 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.926 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.831 ' SG ' ' HA ' ' A' ' 11' ' ' SER . 70.2 m -79.43 100.62 7.74 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.726 HG23 ' H ' ' A' ' 31' ' ' ASN . 6.1 tp -98.46 -66.09 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.757 -170.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.726 ' H ' HG23 ' A' ' 30' ' ' ILE . 92.4 m-20 -96.64 34.98 1.57 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 7' ' ' LYS . . . 83.28 4.66 89.46 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.402 -174.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 5.5 mmt85 -128.75 157.96 39.97 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 17.1 m -77.18 112.76 14.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.531 178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 2' ' ' ILE . 61.4 m -116.98 128.06 54.81 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 175.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.823 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 46.3 m -99.13 128.02 45.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.346 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -110.95 92.52 15.07 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.608 -0.723 . . . . 0.0 110.183 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 10.2 Cg_exo . . . . . 0 C--O 1.25 1.092 0 C-N-CA 123.227 2.618 . . . . 0.0 111.742 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.278 . . . . . . . 0 N--CA 1.474 0.735 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.741 ' HB ' ' HB3' ' A' ' 36' ' ' CYS . 34.0 mm -78.17 100.13 3.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.23 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -90.14 100.34 13.19 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.3 p -72.89 -11.65 60.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.068 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.78 46.1 14.64 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.909 0.861 . . . . 0.0 109.643 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 33' ' ' ARG . 74.2 t -119.83 103.69 14.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.416 -173.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' A' ' 7' ' ' LYS . 27.0 mtmm -56.07 120.98 8.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.602 174.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.9 p -133.53 160.72 36.62 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.344 0.592 . . . . 0.0 112.17 -173.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.8 m -121.8 -0.2 9.66 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.446 170.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.75 143.41 10.75 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.248 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 15' ' ' VAL . 10.7 m -90.56 -26.76 19.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.627 0.251 . . . . 0.0 111.257 -177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.3 t -60.62 -42.54 97.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.061 -170.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.7 mmmm -63.79 -29.18 70.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.772 0.32 . . . . 0.0 110.987 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.55 ' HA ' HG22 ' A' ' 17' ' ' ILE . 98.8 m -85.08 -46.01 11.56 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -177.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.673 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 2.6 p -59.71 -33.57 52.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.623 0.249 . . . . 0.0 111.454 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -79.14 -36.49 40.44 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.057 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' A' ' 20' ' ' ASP . 4.0 tp -85.48 -23.11 7.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.147 0.499 . . . . 0.0 111.405 -174.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.704 ' SG ' HG23 ' A' ' 24' ' ' THR . 41.8 t -63.3 -20.52 65.55 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.14 0.495 . . . . 0.0 110.106 176.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 59.8 mt -75.41 -32.34 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.463 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.643 ' HB3' HD12 ' A' ' 17' ' ' ILE . 12.4 t70 -83.89 -43.9 14.83 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.339 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -68.52 -38.74 81.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.946 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -123.07 -109.38 0.33 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -162.51 4.62 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.053 0.454 . . . . 0.0 111.152 177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.704 HG23 ' SG ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -105.76 154.52 20.38 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.17 0.51 . . . . 0.0 111.415 -170.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.538 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -118.29 16.42 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.808 -168.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -126.2 55.43 0.74 Allowed Glycine 0 C--O 1.224 -0.503 0 C-N-CA 119.684 -1.246 . . . . 0.0 113.554 -173.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.732 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . . . -97.89 130.51 44.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.278 0.539 . . . . 0.0 111.044 -178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 84.8 tttt -130.47 140.72 50.53 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.413 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 35.0 t -81.69 92.29 6.58 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.473 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.2 tp -116.96 -58.37 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -168.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.473 ' H ' HG23 ' A' ' 30' ' ' ILE . 4.3 t30 -95.18 40.74 1.1 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.533 0.682 . . . . 0.0 109.516 -177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.98 -0.52 72.36 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.142 -177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 6' ' ' VAL . 7.3 ptp180 -141.13 165.3 27.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 63.3 m -83.3 106.49 15.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.169 178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 40.8 m -100.49 126.72 46.94 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.741 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -99.76 122.65 43.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.079 -176.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -106.31 96.15 12.96 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.569 -177.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 8.2 Cg_exo . . . . . 0 C--O 1.25 1.079 0 C-N-CA 123.727 2.951 . . . . 0.0 112.14 177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.287 . . . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.791 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 36.6 mt -85.21 104.74 13.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.253 0.549 . . . . 0.0 110.853 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -101.83 122.78 44.63 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 172.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.435 HG22 ' HE2' ' A' ' 22' ' ' TYR . 17.9 p -78.79 -5.04 52.33 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.538 -175.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.5 t30 58.71 39.08 24.74 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 122.602 1.192 . . . . 0.0 109.016 -173.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.8 112.29 23.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 113.851 -1.522 . . . . 0.0 110.036 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.2 mttp -63.07 132.63 52.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 175.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 34' ' ' CYS . 19.6 p -101.53 130.26 47.78 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 121.255 0.55 . . . . 0.0 112.114 -169.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.4 p -106.6 15.3 25.95 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.842 0.829 . . . . 0.0 108.783 169.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.08 137.74 2.28 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.537 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.491 ' O ' HG12 ' A' ' 15' ' ' VAL . 19.4 m -70.06 -26.65 64.12 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.177 0.489 . . . . 0.0 111.641 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -66.42 -43.07 86.75 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -170.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -33.92 75.86 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.282 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 10.2 m -67.13 -58.15 5.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.617 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.556 ' O ' HG13 ' A' ' 19' ' ' ILE . 2.4 p -57.55 -35.35 49.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.18 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.41 -52.92 55.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.226 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 20' ' ' ASP . 2.5 tp -81.43 -24.83 10.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.129 0.49 . . . . 0.0 111.528 -173.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 20.1 t -63.86 -24.48 67.76 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.37 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 15' ' ' VAL . 64.7 mt -74.96 -39.95 45.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.692 176.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.485 ' HB3' HD12 ' A' ' 17' ' ' ILE . 14.4 t70 -76.26 -39.43 54.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.269 0.557 . . . . 0.0 109.792 -175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 21' ' ' ARG . 33.7 mtt180 -67.46 -56.41 9.69 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.344 -0.844 . . . . 0.0 111.021 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.435 ' HE2' HG22 ' A' ' 4' ' ' THR . 59.1 m-85 -109.37 -101.87 0.38 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.428 -172.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -160.39 -15.08 0.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.87 -0.604 . . . . 0.0 112.218 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.457 HG21 ' HB3' ' A' ' 36' ' ' CYS . 4.7 t -101.47 163.92 12.02 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 111.329 -165.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.719 ' H ' ' HD3' ' A' ' 25' ' ' ARG . 0.1 OUTLIER -137.29 13.03 3.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.535 -167.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -125.67 79.37 0.37 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.58 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.17 141.16 47.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.024 0.44 . . . . 0.0 111.029 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -127.54 136.35 51.59 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.504 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 43.9 t -79.67 103.3 9.48 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 169.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.546 HG23 ' H ' ' A' ' 31' ' ' ASN . 4.9 tp -127.97 -64.34 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -169.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.546 ' H ' HG23 ' A' ' 30' ' ' ILE . 95.8 m-20 -95.77 33.71 1.62 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.047 0.451 . . . . 0.0 110.899 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.71 -12.86 67.35 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.716 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -133.48 169.67 16.62 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.874 0.369 . . . . 0.0 110.579 179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 18.8 m -76.31 123.15 25.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.571 178.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 22.8 m -117.46 120.66 38.8 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.196 176.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.791 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 59.9 m -98.99 125.86 44.55 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.415 -179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -105.36 92.68 5.97 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.323 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 15.4 Cg_exo . . . . . 0 C--O 1.247 0.947 0 C-N-CA 123.45 2.767 . . . . 0.0 112.145 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.309 . . . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.682 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 77.3 mt -82.54 98.07 4.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.75 0.31 . . . . 0.0 110.658 179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -108.48 129.23 55.29 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 6' ' ' VAL . 13.8 p -85.96 -0.03 54.45 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.456 -174.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.449 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 62.8 t30 55.29 42.64 30.13 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 122.413 1.101 . . . . 0.0 109.265 -174.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 4' ' ' THR . 54.2 t -129.89 113.26 26.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.167 -1.378 . . . . 0.0 110.097 -174.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -51.62 138.36 22.99 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 123.754 0.659 . . . . 0.0 110.146 176.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 31.3 p -79.0 134.31 36.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.465 0.65 . . . . 0.0 111.598 -168.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 t -96.76 43.21 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.843 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.63 21.79 7.36 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.367 178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.401 ' O ' HG23 ' A' ' 15' ' ' VAL . 91.5 p 65.46 -51.41 0.37 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.923 1.289 . . . . 0.0 113.267 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.0 t -63.22 -36.4 83.52 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 122.552 0.341 . . . . 0.0 111.877 -173.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -50.84 -45.58 59.75 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.153 0.501 . . . . 0.0 110.621 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 34' ' ' CYS . 1.5 m -67.49 -44.06 79.43 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.305 -177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.624 ' HA ' ' HB3' ' A' ' 27' ' ' ALA . 16.2 t -55.82 -40.14 60.02 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.135 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -74.28 -55.53 5.92 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.612 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 20' ' ' ASP . 2.8 tp -77.36 -28.0 16.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -169.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.436 ' SG ' HG21 ' A' ' 24' ' ' THR . 7.8 t -62.49 -26.41 68.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.974 0.416 . . . . 0.0 110.024 178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.483 HG12 ' O ' ' A' ' 24' ' ' THR . 59.5 mt -71.74 -44.91 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.921 177.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.49 ' HB3' HD12 ' A' ' 17' ' ' ILE . 23.3 t70 -68.79 -36.06 77.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.232 0.539 . . . . 0.0 110.425 -175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.73 -45.32 25.05 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.428 -0.806 . . . . 0.0 112.101 -178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -121.81 -114.09 0.32 Allowed 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.422 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -161.73 92.06 0.85 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.287 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.655 HG22 ' HG3' ' A' ' 38' ' ' PRO . 72.8 p -135.68 153.61 51.55 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.297 -176.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HD2' ' H ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -117.46 6.25 12.57 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.059 0.457 . . . . 0.0 109.811 174.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -174.87 127.96 1.36 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.479 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' A' ' 15' ' ' VAL . . . -128.75 159.35 35.96 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 173.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -149.54 155.76 40.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.196 0.522 . . . . 0.0 111.326 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 53.1 t -96.61 100.23 11.81 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.6 tp -99.52 -50.9 10.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.729 -170.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -115.65 19.7 15.12 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.781 0.8 . . . . 0.0 109.709 -177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.25 -7.37 32.56 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.709 178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 10.7 ptt180 -131.31 170.94 13.94 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.585 -0.362 . . . . 0.0 110.888 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 14' ' ' CYS . 32.7 m -75.73 123.25 25.28 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.538 -176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 85.5 m -126.16 122.2 35.0 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.486 172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.682 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 34.2 m -98.07 136.46 38.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.303 -176.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -117.48 84.23 18.3 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.686 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.655 ' HG3' HG22 ' A' ' 24' ' ' THR . 11.4 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 123.268 2.646 . . . . 0.0 111.655 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.28 . . . . . . . 0 N--CA 1.478 0.971 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.778 ' HB ' ' HB2' ' A' ' 36' ' ' CYS . 92.6 mt -99.8 115.55 41.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.71 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -98.9 131.67 44.81 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.8 p -79.7 -22.17 43.72 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.61 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 4.8 t-20 67.58 38.7 3.0 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.092 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -143.14 128.21 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 112.918 -1.946 . . . . 0.0 109.994 -172.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 33' ' ' ARG . 43.4 mtmt -64.99 145.17 56.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.924 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 11.6 p -114.57 152.99 30.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.043 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 p -78.69 -39.48 36.53 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.623 0.725 . . . . 0.0 109.681 174.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.73 169.08 31.17 Favored Glycine 0 N--CA 1.441 -1.011 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.498 176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.583 ' HA ' ' SG ' ' A' ' 29' ' ' CYS . 15.8 p -57.82 -28.43 64.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.937 0.399 . . . . 0.0 111.533 -176.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.578 ' HA ' ' CG1' ' A' ' 15' ' ' VAL . 47.9 t -73.78 -8.33 55.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.229 -174.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -65.86 -53.93 33.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.918 0.389 . . . . 0.0 110.937 -177.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 34' ' ' CYS . 1.2 m -77.17 -40.93 43.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.578 ' CG1' ' HA ' ' A' ' 12' ' ' SER . 6.0 p -57.71 -26.9 28.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -172.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -87.61 -40.89 13.82 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.604 -0.439 . . . . 0.0 111.288 178.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.654 HD12 ' HB3' ' A' ' 20' ' ' ASP . 4.5 tp -85.14 -27.17 6.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.231 0.539 . . . . 0.0 111.738 -172.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 8.7 t -60.75 -21.43 62.99 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.358 0.599 . . . . 0.0 109.826 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 44.2 mt -79.53 -29.96 13.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.075 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.654 ' HB3' HD12 ' A' ' 17' ' ' ILE . 30.3 t70 -85.32 -29.49 24.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.681 0.753 . . . . 0.0 109.945 -174.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 17' ' ' ILE . 55.1 mtp180 -92.03 -43.86 9.18 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.226 -177.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -110.05 -111.5 0.32 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.142 -175.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -162.13 6.41 0.06 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.2 t -115.69 142.52 46.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.356 0.598 . . . . 0.0 111.797 -172.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -98.29 7.48 46.17 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.284 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -110.59 103.25 1.62 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.11 -176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 36' ' ' CYS . . . -142.48 140.04 31.75 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.892 0.377 . . . . 0.0 110.762 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -138.01 142.7 40.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.204 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 82.1 m -80.2 133.42 36.02 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 173.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.437 HG23 ' H ' ' A' ' 31' ' ' ASN . 5.2 tp -121.77 -55.79 3.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.947 -171.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.437 ' H ' HG23 ' A' ' 30' ' ' ILE . 15.8 t-20 -129.95 61.93 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.74 -26.07 2.05 Favored Glycine 0 CA--C 1.517 0.202 0 CA-C-N 115.311 -0.859 . . . . 0.0 112.413 -177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.61 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 37.8 ttp180 -109.25 149.01 30.05 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 8.4 p -95.98 141.86 28.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.133 0.492 . . . . 0.0 111.237 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.6 m -131.18 145.05 51.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.065 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.778 ' HB2' ' HB ' ' A' ' 2' ' ' ILE . 39.8 m -97.75 123.81 41.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.905 0.383 . . . . 0.0 110.306 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -116.6 85.87 17.55 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.161 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 36' ' ' CYS . 17.9 Cg_exo . . . . . 0 C--O 1.248 1.014 0 C-N-CA 122.995 2.463 . . . . 0.0 111.521 176.812 . . . . . . . . 1 1 . 1 stop_ save_